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Abstract 
  
Tart cherries are polyphenol abundant stone fruits claimed to exert health benefits further 
of its nutritional properties. The abundant phytochemicals content in tart cherries also referred as 
dietary polyphenols have been considered as an effective natural antioxidant when added in daily 
diet. However, it has been hypothesized the intervention of gut microbiota on the overall 
functionality of such compounds. This thesis contains a wide-ranging literature review focused on 
tart cherry as a crop, current market, functional food, and several health benefits. Furthermore, the 
research done describes and in vitro and in vivo assays of a short-term dietary intervention of tart 
cherry and polyphenol isolates assessed with microbial ecology analysis and metabolomics of tart 
cherry concentrate polyphenols and microbial metabolites. The concentration of polyphenols 
(anthocyanins, flavonols and phenolic acids) were high amounts as expected. The in vitro assay 
showed large increase of Bacteroides in addition to a suggested Bifidobacterium increase likely 
due to large concentration of chlorogenic acid found in the tart cherry concentrated juice. The main 
microbial metabolites found in this assay was mainly 4-hydroxyphenyl propionic acid and in less 
amounts 4-hydroxybenzoic acid. The in vivo assay showed two initial scenarios associates with 
Bacteroides relative abundance: individuals with high Bacteroides increase the relative abundance 
of Lachnospiraceae, Ruminococcus and Collinsella; on the other hand, individuals with low levels 
of Bacteroides responded with an increase Prevotella and Bifidobacterium and Bcteroides and 
decrease of Lachnospiraceae, Ruminococcus and Collinsella. The results confirm an intervention 
from the gut microbiota over the metabolism of phytochemicals which should be considered in 
studies linked with functional foods and potential benefits to health.  
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fate of phytochemicals in the human gastrointestinal tract 
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ABSTRACT 
 Tart cherries are increasingly popular due to purported health benefits. This Prunus cesarus 
species is cultivated worldwide, and its market has increased significantly in the last two decades 
due to improvements in agricultural practices and food processing technology. Tart cherries are 
rich in polyphenols, with a very specific profile combining anthocyanins and flavonols (berries-
like) and chlorogenic acid (coffee-like). Tart cherries have been suggested to exert several 
potentially beneficial health effects including: lowering blood pressure, modulating blood glucose, 
enhancing cognitive function, protecting against oxidative stress and reducing inflammation. 
Studies focusing on tart cherry consumption have demonstrated particular benefits in recovery 
from exercise-induced muscle damage and diabetes associated parameters. However, the 
bioconversion of tart cherry polyphenols by resident colonic microbiota has never been considered, 
considerably reducing the impact of in vitro studies that have relied on fruit polyphenol extracts. 
In vitro and in vivo gut microbiota and metabolome studies are necessary to reinforce health claims 
linked to tart cherries consumption.  
Keywords:  
Tart cherries, Phytochemicals, Polyphenols, Gut microbiota, Metabolome  
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INTRODUCTION 
Tart cherries (Prunus cerasus) are among the ever-growing list of fruits branded as “super-
foods”. While the superfood concept tends to often rely on speculative assertions, the potential 
health benefits of tart cherries are relatively well documented. The significantly high 
phytochemical content in tart cherries (especially polyphenols) has most commonly been studied 
in the context of health, and there is solid evidence for high antioxidant properties at the very least 
(Blando et al. 2004,Ducharme et al. 2009,Levers et al. 2016,Matchynski et al. 2013,Wojdylo et al. 
2014). 
Functional food is a term broadly used to label foods that help to enhance some functions 
of the body as well as being nutritious (Hasler. 1996). It is important to note that “qualified health 
claims” are stringently regulated by FDA, and thus only few foods marketed as functional foods 
have strong scientific evidence of bringing health benefits. Therefore, tart cherries, like other 
phytochemical-rich fruits, do not fulfill specific health claims (however, like most fruits and 
vegetables containing fibers and vitamins, they fulfill the general claims for reduced coronary heart 
disease and cancer risk). Still, there have been numerous reports of beneficial health impacts from 
consumption of phytochemical-rich fruits (Nile and Park. 2014). Tart cherries are particularly rich 
in polyphenolic compounds such as flavonoids: flavonols and anthocyanins; anthocyanins being 
responsible for the deep red color characteristic of the fruits (Damar and Eksi. 2012, Alrgei et al. 
2016).  
Several studies in recent years have suggested specific beneficial health properties from 
tart cherry consumption, notably a potential to alleviate muscle damage commonly associated with 
prolonged physical effort (Connolly et al. 2006 ,Kuehl et al. 2010,Kuehl. 2012). Tart cherries 
potential for prevention of chronic diseases such as cancer (Kang et al. 2003, Martin and Wooden. 
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2012) and cardiovascular abnormalities (Juhasz et al. 2013,Bak et al. 2006,Csiki et al. 2015), 
diabetes (Mahmoud et al. 2013) as well as inflammatory conditions (Ou et al. 2012,Saric et al. 
2009) has also been reported. However, a significant portion of research has relied on in vitro or 
animal studies with isolated native polyphenolic extracts (in particular, antioxidant properties) 
(Kirakosyan et al. 2015,Kirakosyan et al. 2009,Mahmoud et al. 2014). Polyphenols, which are 
large and complex molecules, are known to be generally poorly absorbed in the small intestine. It 
has been shown that the colonic microbiota (the collection of microbes living in the large intestine) 
modifies and degrades polyphenols to smaller metabolites which become available to the host 
(Bohn. 2014, Bohn et al. 2015, Crozier et al. 2009). There is still only sparse knowledge on how 
fruit polyphenols modulate the gut microbiota, and into which metabolites they break down 
through colonic fermentation (Del Rio et al. 2013a). This represents a major limitation for previous 
in vitro studies using native polyphenols, since human cells/organs are most likely to be exposed 
to phenolic metabolites (Aura et al. 2013,Clifford et al. 2013,Larrosa et al. 2009a,Miene et al. 
2011). Further, the strong individuality in human gut microbiota profiles (Turroni et al. 
2017,Arumugam et al. 2011) and microbiome functions arguably leads to different metabolome 
profiles (Bolca et al. 2013,Tomas-Barberan et al. 2016). The goal of this review is to present the 
current knowledge on tart cherries as a high value crop and describe the reported potential health 
benefits. The limited knowledge on gut microbiota modulation of tart cherries phytochemicals will 
also be presented. 
TART CHERRY ECONOMIC IMPORTANCE 
 
Cherry trees (genera Prunus) are represented by two subgenera, Padus (bird cherries) and 
Cesarus, however most berries of agricultural importance belong to the Cesarus subgenus. More 
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specifically, the two-main species grown worldwide are Prunus avium (sweet cherries) and Prunus 
cesarus (tart or sour cherries) (Brown-Skrobot et al. 1989). Cherries are considered high-value 
crop produced worldwide largely because of their purported health benefits (Bak et al. 2010, Bell 
et al. 2014a) rather than organoleptic properties. The current review will be focused on tart 
cherries. 
Worldwide, tart cherries production has increased significantly in the last decades because 
of advances in agricultural practices, food technologies and raising global demand; from 2,154,000 
to 3,057,000 metric tons. Europe leads the production with 65.8% of the total world production 
followed by Asia and America with 24.9% and 9.3% respectively (FAOSTAT, 2015). In 2013, the 
top five producer countries of tart cherry were Ukraine, Russian Federation, Poland, Turkey and 
the United States of America (USA). The USA produced 268,072 metric tons in 2013 and 2014 
valued at more than $210 million. Michigan, Utah, and Washington are the three states with the 
highest production (USDA NASS, 2014). During the past decade, USA has been a leading exporter 
of this commodity and lately Chile has joined the export market, mainly to China, Russia and 
South Korea. Tart cherry production has increased due to recent improvement in agricultural 
practices, allowing producers to sell fruits at reasonable prices (Webster and Looney. 1995), before 
necessary processing into concentrate, juice, wine, brined, dried and powder, which have better 
palatability (Kirakosyan et al. 2009, Webster and Looney. 1995). 
PRE AND POST-HARVEST AND PROCESSING SPECIFICITIES 
 
Tart cherry cultivars are the most tolerant plants to biotic and abiotic stress among their 
family (Rosaceae). However, during harvest tart cherries become susceptible to hot-dry weather, 
which reduces the harvest window and can be the cause of significant physico-chemical changes 
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affecting color, polyphenol content and the detachment force, thus affecting the overall production 
(Aslantas et al. 2016). Appropriate harvest and postharvest handling are critical for higher quality 
of the commodity, however 55% of the total cost is spent when cherries are hand-harvested. In 
contrast mechanical harvesting was shown to lower the cost and enhance profits for the industry 
(Webster and Looney. 1995).  
Tart cherry is a non-climacteric fruit, thus the variability of maturity throughout the tree 
influences quality and yields during harvest and processing. Industrial tart cherry processors rely 
on methods to determine optimum physio-chemical parameters of maturity including the fruit 
detachment force (FDF) and color parameters (Aslantas et al. 2016) . The color characteristics, 
specifically the color intensity, have been reported to be an effective field indicator of maturity 
stage in cherry. Aslantas et al. ( 2016) researched a standard procedure to determine the degree of 
maturity for harvest based on the fruit detachment force and fruit pomological and chemical 
characteristics. Tart cherries were classified into five stages of maturity per physical characteristics 
such as color and size by observation, where higher values meant higher level of maturity. The 
results indicated a strong relation between the physicochemical characteristics and the stage of 
maturation in the fruit; where the best three categories of maturity stages showed higher efficiency 
in poundage per tree, as well as improved homogeneity of color and reduced fruit detachment 
force. Ascorbic acid levels tend to decrease when maturity increases as degradation of organic 
acids occur, which is a desirable quality in the juice industry (Wojdylo et al. 2014,Karaaslan et al. 
2016).  
Around 95% of the tart cherry production is intended for industrial purposes; representing 
a great challenge for new processing technologies able to preserve bioactive compounds available 
for consumption. The production of juice accounts for about half of the tart cherry production 
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destined to industry. Turkey, one of the largest producers, utilizes around forty percent of the tart 
cherries in production of juice or nectar because of the market demand and accessible handling for 
commercialization (Damar and Eksi. 2012). The rest of the production is distributed into frozen, 
purees, dried pitted tart cherry, powder from individually quick frozen (IQF), and concentrates. 
Every product undergoes different treatment technologies that have an impact on the content of 
bioactive compounds which varies according to the type of product. Table 1 presents an exhaustive 
list of the processing steps that tart cherries undergo to be converted to juice. In the production of 
juice, mash press extraction has been shown as the key step for optimal phenolic compounds 
recovery. To improve extraction three rinses are necessary to increase the recovery yield of 
bioactive compounds, reaching 83% of anthocyanin and 62% of procyanidins (oligomeric 
flavonoids) from the press cake (Toydemir et al. 2013b). The total extraction of these compounds 
is remarkably high in comparison to other fruits such as blueberries (Skrede et al. 2000); and two 
properties may explain this phenomenon. First, the molecular structure of the anthocyanin profile 
in tart cherry is dominated by water soluble chemical groups (tri-glycoside), which may increase 
the recovery of anthocyanins. Second, anthocyanins in the fruits are found mainly in the flesh 
facilitating disruption and enabling a higher yield of bioactive compounds in the end-product 
(Capanoglu et al. 2013,Toydemir et al. 2013a). Transformation of rich polyphenol plants tissues 
to processed products leads to changes in the phenolic profile with the formation of derived 
polyphenols (Crozier et al. 2009). The addition of sweeteners in cherry products has been shown 
to induce a slight decline in polyphenol concentration, especially the anthocyanins. Nevertheless, 
these products are more attractive to consumers and are still able to provide a high antioxidant 
activity and potential health benefits (Nowicka and Wojdylo. 2016). 
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Nutritional and health claims have substantially increased the demand of tart cherry in the 
industry and have generated interest of research in preservation and stability of the phytochemicals 
content and bioavailability in tart cherry after processing (Seeram et al. 2001a). During processed 
tart cherry products storage, physicochemical reactions take place where the antioxidant 
compounds are converted or degraded, and color may be altered. The concentration of 
polyphenolic compounds can also change due to enzymatic oxidation to quinones (Bonerz et al. 
2007). Monomeric anthocyanins are the most affected by the storage steps that the products 
undergo. Furthermore, long term storage had been reported to affect the polyphenol profile and 
contents. Storage at 20°C for 6 months resulted in formation of polyphenol derivatives and 
significant decline (70–75%) of anthocyanin concentration (Bonerz et al. 2007). Also since this 
last step is key, packaging alternatives were tested to identify the most effective storage route for 
product quality (freeze-dried sour cherry) and polyphenols integrity. This study showed that most 
of polyphenols remain stable and in high concentration except anthocyanins which decreased by 
62% after one-year storage at lower temperatures (Zoric et al. 2016). This kind of food storage 
allow year-round tart cherry products availability, hence proper food processing practices to 
preserve the bioactive components is beneficial not only for the industry but for the consumers.  
TART CHERRY PHYTOCHEMICALS 
 
Phytochemicals are secondary metabolites, non-nutritive molecules produced naturally by 
plants (Dillard and German. 2000) as a response to abiotic and biotic stress especially climate 
variation, mechanical damage, as well as a response to pathogen attack (Hirschi. 2009). Certain 
secondary metabolites are classified as phytochemicals if their chemical structure can provide 
potential health benefits over basic nutritional value (Dillard and German. 2000,Tsao. 2010). 
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Phytochemical profiles are extremely variable across plant species (and even variety/cultivar); and 
environmental factors such as growth conditions, soil type and seasons result in further variability 
(Hirschi. 2009, Webster and Looney. 1995). 
Cherries in general have been described as phytochemical rich fruits with potential health 
benefits, while reports on their phytochemical profiles have been somewhat conflicting 
(Kirakosyan et al. 2009,Kirakosyan et al. 2010,Ou et al. 2012). While there is convincing evidence 
that phytochemicals in general are safe to consume, one should remember that in vitro experiments 
that constitute a large fraction of our current knowledge are only partially representative of actual 
human metabolism and physiology (Nile and Park. 2014, Steinberg et al. 2003, Amin et al. 2015, 
Bak et al. 2006). Moreover, the interaction between phytochemicals may result in changes in 
physio-chemical characteristics such as solubility, stability and bioavailability of the active 
compounds in the products (Kirakosyan et al. 2010). Total polyphenol, monomeric anthocyanins, 
and ascorbic acid are well known to possess remarkable anti-oxidant properties (Moyer et al. 
2002,Seeram et al. 2008, Del Rio et al. 2013b, Landete. 2012, Redondo et al. 2017). However, 
most of the antioxidant response was thought to come from the anthocyanins fraction but it actually 
derives mostly from phenolic acids (Damar and Eksi. 2012). 
The phytochemicals in tart cherries are carotenoids and phenolics: phenolic acids and 
flavonoids (Damar and Eksi. 2012, Blando et al. 2004, Kirakosyan et al. 2009).  
Phenolics 
 
Phenolics are secondary metabolites produced by plants which have at least one aromatic 
ring with a single or several hydroxyl groups attached, ranging from simple low molecular weight 
up to complex large molecules such as tannins. Some phenolics are synthesized from 
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carbohydrates following shikimate and phenyl propanoid pathways (Ferretti et al. 2010) . The 
distribution and concentration of phenolics varies within each tree and within the fruit as shown in 
Table 2. Montmorency tart cherry cultivar have highest phenolic content in their skin, leading to 
higher antioxidant capacity (Chaovanalikit and Wrolstad. 2004). The synthesis and accumulation 
of phenolics in the skin is used as a natural harvest indicator, provides organoleptic characteristics 
to the fruit constituting a natural defensive mechanism.  
 
The phenolic compounds in tart cherry contribute to their sensorial attributes like color and 
flavor (Ferretti et al. 2010) (Table3). There is also a great interest on the preventive functionality 
that phenolic compounds have shown in several animal and human models exposed to chronic 
and/or long-term diseases such as, cancer or diabetes and associated features such as oxidative 
stress.  
For a clearer understanding, phenolic compounds are classified into flavonoids and non-flavonoids 
(Bravo. 1998, Tsao. 2010). 
Flavonoids 
 
Flavonoids have attracted interest because of their influence as health promoter 
compounds. The widely-studied anthocyanins are well known for their antioxidant capacity 
(Casedas et al. 2016,Khoo et al. 2012,Wojdylo et al. 2014)(Khoo and others 2011; Wojdylo and 
others 2014b; Casedas and others 2016; Nowicka and others 2016). Other flavonoids include 
flavonols, flavones, flavanols, flavanones, and isoflavones. Flavonoids are recognized for their 
ability of scavenge hydroxyl and peroxyl radicals and also function in synergy with other 
antioxidants and other bio-compounds such as tocopherol and ascorbic acid. 
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Anthocyanins 
 
Anthocyanins are synthetized mainly during ripening and are responsible for the color 
change from green to deep red (Karaaslan et al. 2016). Tart cherries have been shown to contain 
high levels of anthocyanins and phenolic acids which have an inverse relationship: during early 
stage the fruit is high in phenolic acids, while anthocyanins synthesis increases towards ripening 
(Karaaslan et al. 2016,Wojdylo et al. 2014,Blando et al. 2004,Damar and Eksi. 2012), resulting 
in the characteristic deep red color of tart cherries. Since color means such an important parameter 
for harvest and sensorial control, Kim et al (Kim et al. 2005) also evaluated the total content of 
anthocyanins in cherries using two approaches: a colorimetric assay and HPLC. While comparing 
both methods the anthocyanin levels from both were almost the same, meaning that the total count 
of anthocyanins colorimetric assays gave a similar result when compared with the sum of 
individual anthocyanins analyzed with HPLC.  
Several factors strongly affect the anthocyanin content such as genetic background and 
environmental characteristics (Karaaslan et al. 2016) or if the tart cherries are analyzed as fresh 
fruit or as processed product (Kirakosyan et al. 2009). However, the major fraction corresponds 
to Cyanidin-3-glucosyl-rutinoside, accounting for approximately 70% of the total anthocyanin 
concentration (Blando et al. 2004,Chaovanalikit and Wrolstad. 2004, Daenen et al. 2007, Kang et 
al. 2003, Seeram et al. 2001, Tall et al. 2004). Anthocyanins have been reported to be the major 
phenolic in tart cherries,in particular cyanidin and peonidin aglycones and anthocyanidins (Fang 
2015) (Table 4). 
 
Although, anthocyanins are the major compound in tart cherries, they are also the most 
unstable and handling in industrial levels is a challenge (Chaovanalikit and Wrolstad. 2004, 
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Kirakosyan et al. 2009, Zoric et al. 2016). Vesna et al ( 2016) developed a cookie taking advantage 
of the positive interaction between proteins and phenolics, resulting in a satisfactory retention of 
anthocyanins (19-59%). 
Flavonols 
 
Flavonols are a subclass of flavonoids that are naturally produced by plants with important 
antioxidant potential (Kirakosyan et al. 2009). The reported flavonols content in cherry products 
vary significantly, this phenomenon can be due to several causes such as the kind of product itself, 
the conditions it was subjected during processing as well as to the environmental and agricultural 
conditions where the plant was grown (Toydemir et al. 2013b). In a study of interaction of isolated 
polyphenols from tart cherry fruits, it was found that kaempferol and quercetin were the primary 
contributors of the antioxidant (TEAC) properties (Kirakosyan et al. 2009), with Trolox equivalent 
antioxidant capacity (TEAC) values of 4.5 mM TEAC and 4.2 mM respectively. The flavonols 
reported from tart cherry products are kaempferol-3-rutinoside, quercetin-3-glucoside, quercetin-
3-rutinoside, quercetin-3-(2-glucosyl-rutinoside) and isorhamnetin rutinoside (Table 5). They 
were found to be fairly stable in tart cherry juice stored six months at freezing temperature (-25°C) 
(Bonerz and others 2007a; Li and others 2008). 
 
Phenolic acids 
 
Phenolic acids are non-flavonoid polyphenolic compounds recognized for their strong 
antioxidant activity; and divided into two subclasses: hydroxyl-benzoic acids and hydroxyl-
cinnamic acids. Recent studies reported that tart cherries are rich in chlorogenic and 
neochlorogenic acids (Table 6), which have only been described in similarly high quantities in 
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coffee (Karaaslan and others 2016; Casedas and others 2016) and in lower abundances in apricots 
and blueberries (Cho et al. 2004,Dragovic-Uzelac et al. 2007). 
 
Carotenoids and other phytochemicals 
 
While carotenoids are assumed to be present in tart cherries, there have been no reports on 
detection and quantification specifically on tart cherries. Carotenoids, including α and β-carotens, 
lutein and neoxanthin have been detected in wild cherries; however total carotenoids levels did not 
exceed 12.6 mg/kg, whereas carotenoids-rich vegetables often contain hundreds of mg/kg of just 
one of these carotenoids (Mikulic-Petkovsek et al. 2016). Carotenoids have been reported to be 
present in sweet cherries (McCune et al. 2011), however original reports could not be tracked back. 
Carotenoids were also detected in very low levels (0.02 mg/g DW) in cherries (presumably sweet) 
in comparison with carrots and bell peppers in a study conducted in New Zealand (Leong and Oey. 
2012). 
The potentially antioxidant melatonin (N-acetyl-5-methoxytryptamine) had been reported in high 
levels in tart cherries (Burkhardt et al. 2001), however more recent reports indicated that melatonin 
was in low concentration in Montmorency and Balaton tart cherries and completely absent in 
processed tart cherry products (Kirakosyan et al. 2009). Finally, tart cherries contain relatively low 
(3-9 mg/100 g) amounts of ascorbic acid (Vitamin C) (Papp et al. 2010), confirming that tart 
cherries antioxidant potential mainly derive from phenolic compounds. 
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IMPACT ON NUTRITION AND HEALTH 
There are several studies suggesting health promoting benefits could be associated to tart 
cherries consumption including effects on chronic diseases such as cancer, diabetes and cardiac 
complications (Bajerska et al. 2016, Czompa et al. 2014, Bobe et al. 2006, Martin and Wooden. 
2012, Saleh et al. 2017). These studies have generally focused on the content and functionality of 
phytochemicals of tart cherries and connected specifically with the antioxidant activity. 
Nutrition  
 
Tart cherry fruits have somewhat unremarkable nutritional composition (Table 7), with low 
fiber and vitamin C content, but represent a good source of minerals and vitamin A. In addition, 
the necessary food processing tends to even lower the contents of valuable nutrients. One 
advantage is that unsweetened tart cherries products have low sugars and calories. 
Tart cherries impact on exercise 
 
The antioxidant effect phytochemicals in powdered tart cherry has been suggested to improve 
muscle function recovery and reduce inflammation, oxidative stress and pain associated with 
intensive exercise (Bell et al. 2014a). Consumption of tart cherry juice blend have been shown to 
reduce significantly muscle damage symptoms caused by intensive strength exercise or running in 
humans (Connolly et al. 2006,Kuehl et al. 2010,Howatson et al. 2010,Bowtell et al. 2011) and 
horses (Ducharme et al. 2009).Tart cherries supplementation intake was shown to improve the 
average of race pace, as well as modulating the balance in oxidative stress, decreasing 
inflammation markers and improving muscle recovery (Levers et al. 2015,Levers et al. 2016). 
Another study investigated the potential effect of tart cherry concentrate on muscle recovery after 
prolonged and intermittent exercise such as soccer Tart cherry supplementation resulted in faster 
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recovery and lower muscle soreness suggesting modulation of oxidative stress and inflammation 
post-exercise (Bell et al. 2016). Similar results were reported in water-polo players consuming tart 
cherry products (McCormick et al. 2016) as well as other type of high intensity exercise (Bell et 
al. 2015) including cycling (Bell et al. 2014b). Another concern about extended exercise recovery 
has to do with airway inflammation (respiratory mucosal inflammation) directly linked with 
induced pulmonary stress. Tart cherry juices seemed to have a modulatory effect as well as 
reducing inflammatory markers in the respiratory tract of healthy athletes, leading to faster 
recovery (Dimitriou et al. 2015). 
Antioxidant and anti-inflammatory potential 
 
Tart cherries have been shown to modulate inflammatory and oxidative stress expression in 
HAPI cells (rat microglial cells) such as nitric oxide, inducible nitric oxide synthase and 
cyclooxygenase-2 in dose and time dependent manner (Shukitt-Hale et al. 2016a). The 
inflammatory activity in the hippocampus of older rats, measured through COX-2 expression, 
decreased significantly after six weeks of tart cherry supplementation (Thangthaeng et al. 2016). 
Similar anti-inflammatory potential was observed in mice consuming tart cherry juice (Saric et al. 
2009). A double-blind, placebo-controlled, crossover dietary intervention demonstrated that 
consumption of tart cherry juice improved the ability of older men and women to resist oxidative 
damage and stress (Traustadottir et al. 2009). Another study demonstrated that various tart cherry 
products possessed remarkable antioxidant (ORAC properties), but that concentrates in particular 
have higher anti-inflammatory properties as measured by COX-1 inhibition in vitro (Ou et al. 
2012). 
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Tart cherry have also been used as supplementation for treatment of rheumatoid arthritis, in 
this case tart cherry seeds were used to investigate its promoting health activity over inflammatory 
disorder. Blood leukocytes from rheumatic arthritis patients were used and subjected to 
lipopolysaccharide and seeds extract for 24 hours and was reported a decreased expression of heme 
oxygenase-1 (inflammatory marker) that control oxidative stress and therefore intervene on 
inflammation expression (Mahmoud et al. 2014,Mahmoud et al. 2013). 
 
POTENTIAL IMPACT OF METABOLIC DISEASES 
Diabetes and Obesity 
 
Phenolic compounds have shown promising results associated with neutralization of development 
and progression of diabetes and its complications (Lachin. 2014). Although further in vivo studies 
are needed, this may represent an alternative to current treatments. 
Two enzymes are in charge to hydrolyze carbohydrates: pancreatic alpha-amylase and 
intestinal alpha-glucosidase needed to break down to monosaccharides. Therefore, one postulated 
manner to control hyperglycemia and type 2 diabetes is to interfere the role of these enzymes. 
Nowicka et al ( 2016) showed effective inhibition of those enzymes in in vitro assays through 
consumption of smoothies made of tart cherry and other fruits rich in phytochemicals. Comparable 
in vitro results were found with tart cherries anthocyanins having inhibitory activity towards alpha-
amylase (Homoki et al. 2016).  
A recent study was carried out to evaluate the hypoglycemic effect of tart cherry extracts 
in acute and sub-chronic injections to mice, both leading to dose-dependent restorative effects. The 
acute injection resulted in a decrease of blood glucose level and the sub-chronic scenario an even 
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stronger amelioration of glucose levels as well as effects on weight loss and oxidative stress and 
significant pancreatic cell regeneration (Saleh et al. 2017). Another health problem associated with 
diabetes is obesity and the harmful impact of adiposity over metabolism. Here again the 
consumptions of tart cherry extracts also resulted in lower blood glucose in obese mice fed with 
polyphenol-rich cherry extract after food deprivation. The extract consumption also reduced lipid 
accumulation, adiposity accumulation in the liver tissue and remediate the uncontrolled  
accumulation of fat cultured cells (Snyder et al. 2016) .  
 The potential to use by-products such as pomace of juice production has been considered 
due to the elevated content of phytochemicals. A human randomized crossover trial (one test meal 
followed by glycemic response measurements) was performed using tart cherry pomace as 
ingredient of muffins replacing part of the flour (20 or 30%). The results in terms of controlling 
glucose levels were similar to other studies mentioned before but the enriched muffins were also 
effective managing hunger and food intake. Those food products could be a suitable alternative 
for a healthy breakfast or snack in additions to its sensorial acceptance (Bajerska et al. 2016).  
 Certain phytochemicals are also associated with antihyperlipidemic effect. An 
investigation in rats showed reduction of lipid accumulation in liver tissue, which appeared to be 
linked with phenolic acids in tart cherry such as chlorogenic acid and more specifically its 
metabolites rather than anthocyanins. Such metabolites may have a connection with enzymes of 
hypocholesterolemic functions (Papp et al. 2015). In a similar way another study was done with a 
cell culture model which explained a dose-dependent influence decreasing lipid accumulation 
when the cells are expose to 100 µmol/L of quercetin (Snyder et al. 2016). More studies will be 
needed to conclude on the potential antihyperlipidemic and antiadiposity properties of tart cherries. 
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Cardiovascular disease 
 
Cardiovascular dysfunction is a leading cause of death among chronic diseases in 
industrialized countries. Polyphenol-rich fruits have seen increased interest for potential 
cardiovascular health protective effects (Habauzit and Morand. 2012,Habauzit et al. 2015). Tart 
cherries kernel extracts were shown to alleviate ischemia reperfusion-induced damage in isolated 
rat (Bak et al. 2006) and rabbit (Juhasz et al. 2013) hearts. Only marginal impact was observed 
when humans where given similar extracts in a limited double-blind study (Csiki et al. 2015). 
An acute, placebo-controlled, double-blinded, cross-over, randomized intervention was 
performed in a group of middle age volunteers with early hypertension. Volunteers consumed tart 
cherry concentrates (60mL equivalent to 180 cherries). The concentrate consumption was effective 
in reducing their systolic blood pressure but not microvascular reactivity nor arterial stiffness. This 
effect maybe associated to the phenolic acids content and could be extended to other rich 
phytochemical fruits which can serve as systolic blood pressure modulators (Keane et al. 2016b). 
Another study reported no detectable effect on the same cardiovascular disease biomarkers, 
however the study focused on healthy subjects consuming only 30 mL of the same concentrate 
(Lynn et al. 2014). 
 
 Other potential health benefits 
 
Tart cherries consumption was shown to improve the working memory in aged rats having 
an influence on reducing inflammation linked with aging and therefore promoting delay on 
neurodegenerative diseases (Thangthaeng et al. 2016). Furthermore, tart cherry anthocyanins were 
reported to accumulate in brain cells of rats after three weeks in a dose-dependent manner as well 
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(Kirakosyan et al. 2015). Casedas et al ( 2016) reported that tart cherry juice may have protective 
effect against neurological diseases, with antidepressant and anxiolytic properties, possibly due to 
the ability to inhibit  monoamine oxidase A and tyrosinase. In addition, another study showed 
improved memory and cognition in older adults affected with dementia through consumption of 
(sweet) cherry juice (Kent et al. 2017) 
Tart cherries, in fact all cherries; have been increasingly suggested as beneficial to reduce 
the risk of gout attacks, a specific inflammatory arthritis condition. However, FDA has warned 
several cherry producers about claims based on unsubstantiated data, and an epidemiological 
dietary study provided limited evidence for potential gout protective effect (Zhang et al. 2012) and 
a later internet based survey suggested that any correlation seen may be due to the fact that patients 
with milder symptoms are more likely to consume cherries or other plant-based supplements and 
no treatment, effectively skewing the data (Singh et al. 2015). However, a human study showed 
that tart cherry concentrate consumption resulted in significant decrease of plasma uric acid, which 
is purported as the main driver of gout attacks (Bell et al. 2014c). 
  
FATE OF CHERRY POLYPHENOLS IN THE DIGESTIVE SYSTEM 
 
It has been assumed for a long time that the impact of polyphenols on health could be identified 
by exposing human cell lines to more or less purified fractions from fruits (or other plant material) 
(Haddad et al. 2013,Hanbali et al. 2013,Mahmoud et al. 2014,Mahmoud et al. 2013,Martin and 
Wooden. 2012, Shukitt-Hale et al. 2016b). However, it is also well known that most polyphenols 
cannot be absorbed by cells or reach the blood circulation due to their high molecular size (Moco 
et al. 2012a, Marin et al. 2015). In the mammalian digestive system, large non-digestible dietary 
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molecules are subject to fermentation, modifications and degradation by the resident microbes 
(designed under the terms microbiome or microbiota) (Sheflin et al. 2017). The human colonic 
microbiome has therefore become the subject of intense research (Flint et al. 2012,Holmes et al. 
2011), in particular in relation to health and diseases (Candela et al. 2014,Carbonero et al. 
2012b,Carbonero et al. 2012a,O'Keefe et al. 2015,Everard and Cani. 2013, Sartor. 2008, Kostic et 
al. 2014) It is now well known that diet composition strongly influences the gut microbiome 
taxonomic composition and metabolic functions (Flint. 2012, Sheflin et al. 2017). A corollary 
research field is metabolomics; the study of the metabolites deriving from gut microbe activities 
(Wishart et al. 2016, Moco et al. 2012b). The human metabolome is known to include thousands 
of small molecules detected in stool, urine and blood; which are far more bioavailable than parent 
molecules. As far as we know, there has been no attempt to decipher the impact of tart cherries 
consumption on the human gut microbiome and metabolome. Therefore, in this section, we will 
describe the potential effects based on published data on relevant pure polyphenols or fruits/plants 
with similar polyphenolic profiles. 
Polyphenols and polyphenol-rich food impact on the gut microbiota 
 
Several reviews on the impact of dietary polyphenols on the gut microbiota are available 
(Duda-Chodak et al. 2015,Tomas-Barberan et al. 2016,Sheflin et al. 2017). The two genera that 
are reported the most often as being stimulated by polyphenols are Bifidobacterium and 
Lactobacillus, both known for their probiotic properties (Larrosa et al. 2009b,Chen et al. 2016,Li 
et al. 2015,Espley et al. 2014,Faria et al. 2014a,Mills et al. 2015). In addition, it has been shown 
that those genera are the primary converters of quercetin (Zhang et al. 2014), and chlorogenic acid 
(Ludwig et al. 2013), while their role in bioconversion of other polyphenols remains elusive. 
Quercetin has been shown to be degraded by Escherichia coli and Bacteroides fragilis (Zhang et 
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al. 2014). Isoflavones are converted by Aldercreutzia spp. and Slackia spp (Guadamuro et al. 
2017). Elagitannins were found to increase the numbers of Akkermansia in vivo (Li et al. 2015). 
Tea, coffee, cocoa, berries mango and pomegranate, all rich in polyphenols were all found to 
stimulate Lactobacillus and Bifidobacterium (Jaquet et al. 2009,Bialonska et al. 2010,Ojo et al. 
2016,Jakobsdottir et al. 2013,Truchado et al. 2012,Puupponen-Pimiä et al. 2013,van Duynhoven 
et al. 2013). The main exception is lingonberries, which have been shown to increase 
Faecalibacterium, Bacteroides and Clostridium levels (Heyman-Linden et al. 2016,Matziouridou 
et al. 2016).  
To the best of our knowledge, there have been no in vitro, animal or human dietary intervention 
studies on the impact of tart cherries (and sweet cherries) consumption on the gut microbiome. 
Based on cherries polyphenolic profiles, stimulation of Lactobacillus, Bifidobacterium and/or 
Bacteroides can be hypothesized, but the bioavailability of specific polyphenols in various tart 
cherry products probably influence their impact on gut microbiota. It can be hypothesized that 
other phytochemicals would have limited impact because of very low concentration; and the near-
absence of fibers suggests that tart cherries would provide low amounts of polysaccharides for 
microbial fermentation. 
 
Microbial derived metabolites from dietary polyphenols 
 
Isoflavones have been studied extensively because microbial biotransformation leads to the 
very beneficial equol metabolite (Setchell and Clerici. 2010, Setchell et al. 2002). However, it was 
also shown that equol production is not universally distributed (Frankenfeld et al. 2014, Reverri et 
al. 2016) leading to the concept of metabotypes. While the potential health benefits of resveratrol 
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have been put under scrutiny, it is known that equol producing bacteria are able to convert trans-
resveratrol to dihydroresveratrol (Bode et al. 2013). There is extensive evidence that elagitannins 
are converted to urolithins (Espin et al. 2013,Selma et al. 2014,Puupponen-Pimia et al. 
2013,Gimenez-Bastida et al. 2012) and proanthocyanidins to phloroglucinol and benzoic acid 
derivatives: gallic, syringic and coumaric acids (Faria et al. 2014b,Hanske et al. 2013).  
Metabolomics studies have been conducted on different food types. Tea catechins were found 
to be converted to conjugated catechins, valerolactones, valeric acids and other phenolic 
acids(Grun et al. 2008, Gross et al. 2010). Berries and pomegranate were shown to enrich 
metabolomes in urolithins, phloroglucinol and benzoic acid derivatives (Truchado et al. 2012, 
Jakobsdottir et al. 2013). Studies on citrus fruits, which are rich in esperetin, naringenin, and ferulic 
acid, showed microbial production of different hydroxyphenyl propionic acids(Pereira-Caro et al. 
2015). 
Chlorogenic acid from coffee was shown to be converted to dihydrocaffeic acid, dihydroferulic 
acid, and 3-(3'-hydroxyphenyl) propionic acid in rats (Gonthier et al. 2003) and in humans (Ludwig 
et al. 2013). The anthocyanin cyanidin-3-glucoside was shown to be converted mainly to phenolic, 
hippuric, phenylacetic, and phenylpropenoic acids in humans through isotope pulse-chase studies 
(Czank et al. 2013). These metabolites were shown to modulate vascular reactivity (Edwards et al. 
2015) and reducing the expression of inflammatory mediators (Amin et al. 2015) in vitro. 
Protocatechuic acid in particular has been reported as the main metabolite of gut microbiota 
fermentation of cyaniding glucosides  and has been shown to exert several potential health benefits 
(Amin et al. 2015,Hornedo-Ortega et al. 2016,Olivas-Aguirre et al. 2016,Wang et al. 
2016,Woodward et al. 2011,Seeram et al. 2001b). It is expected that similar metabolites are 
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produced through gut microbiota fermentation of tart cherries, though it is possible that the unique 
polyphenol profile results in different metabolic pathways and metabolomics profiles. 
 
Conclusions and perspectives 
 
This review provides an update on the current investigation in regard to the promising 
phytochemicals content in tart or sour cherries. Improvements in agricultural practices and 
processing combined with health claims have resulted increased worldwide production. Health 
claims are mainly associated with high polyphenol concentration, as well as specific profile. 
However, it is necessary to determine the fate of those polyphenols in the human gastrointestinal 
tract. Based on studies on other polyphenol-rich fruits, it is expected that tart cherries consumption 
has potential to significantly modulate the gut microbiota composition and metabolic activities, 
leading to the release of specific phenolic metabolites. The potential health benefits of modulated 
gut microbiota and phenolic metabolites presumably differs from health properties described by 
in vitro studies of native polyphenols extracts from tart cherries. 
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Table 1: Description of tart cherry juice processing steps. 
Processing step 
Treatment & 
conditions 
Aim Weight data 
Fresh fruit Washing and selection 
Removal of unwanted 
material 
3.5% reduction in wet-
weight 
Fresh fruit and 
stalk 
Separation of stalks Stalk removal 
2% and 4% reduction 
in wet- and dry-weight 
bases 
Mash heat 
Mash heating              
80°C for 90s  
Enzyme inactivation No change 
Mash press 
Pressing; 110bar- 
horizontal press 
Obtaining the juicy 
part 
73% juice yield 
Mash press cake 
extract  
Mash press extraction- 
(repeated 3 times) 
Increasing the yield of 
juice 
Juice yield increased to 
85% 
Press cake with 
seeds 
Press cake resulting 
after mash press 
Removal of insoluble 
fruit parts 
15% reduction wet-
weight; 29% dry-
weight 
Pasteurized 
juice 
Pasteurization of 
pressed juice; 95°C for 
90s 
Microbial inactivation No change 
Enzyme treated 
juice 
Enzymation; 50°C for 
2h 
Degradation of pectic 
substances and starch 
pectolytic enzyme and 
amylolytic enzyme 
Clarified juice 
Clarification; 50°C 
for1h 
Precipitating haze 
precursors 
780 g gelatin/t juice1.2 
kg bentonitef/t juice 
Filtered juice 
and filtration 
residue 
Ultrafiltration 
Obtaining the clear 
juice by removing 
precipitates 
6% and 7% reduction 
in wet- and dry-weight 
-  
Concentrated 
juice 
Evaporation to 65˚Brix 
(Bx); 65-80°C 
Volume reduction for 
storage 
12.5˚Bx evaporated to 
65˚Bx 
Non-paper-
filtered and 
paper-filtered  
Paper filtration 
Elimination of 
Alycyclobacillus 
bacteria 
Negligible 
Nectar 
Addition of sucrose and 
citric acid 
Production of nectar 
56% sucrose on dry-
weight basis with: 
Pasteurized 
nectar 
Pasteurization of final 
nectar; 95°C for 45s 
Microbial inactivation   
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Table 2: Polyphenols distribution and concentration in the tart cherry fruit.. 
Cultivar Portion 
Anthocyanins (mg cy-3-
glu/100gfw) 
Total phenolics (mg GAE/g 
fw) 
ORAC (μmoles 
TE/g fw) 
FRAP 
(μmolesTE/g fw) 
Montmorency 
Flesh 0 ± 0.1 3.± 0.3 15 ± 1 13.8 ± 0.3 
Pits 0.8 ± 0.1 1.6 ± 0.02 9.8 ± 0.3 8.5 ± 0.9 
Skins 36.5 ± 1.6 5.6 ± 0.3 51 ± 2 48 ± 1.3 
 
 
 
 
 
 
 
 
 
4
0
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Table 3: Phytochemical profiles and antioxidant properties in different tart cherries food products. 
Product Total anthocyanin Phenolic acids Total phenolic 
Antioxidant 
capacity 
Reference 
Puree (mg/100g) 21.5-25.1 9.3-23.3 147.2-200  
(Nowicka and 
Wojdylo. 2016) 
Fruit (Italian 
cultivars) 
(mg/100g) 
27.8-80.4 
 
2000-2600 
μmol TE/100g 
fw 
(Blando et al. 2004) 
Fruit (Turkish 
cultivars) 
(mg/100g) 21-285    
 (Damar and Eksi. 
2012) 
Fruit (Turkish 
cultivars) 
(mg/100g) 45  275.4 
19 mmol 
TE/Kg 
(Karaaslan et al. 
2016) 
Dried (μg/g) 62-564a  3522-7813
b 3.3.5 mmol/L 
(Kirakosyan et al. 
2009) 
frozen(μg/g) 533-1741a  6742-12665
b 
4.4-4.5 
mmol/L 
Concentrate (μg/g) 213-722a  2541-4013
b 3.5 mmol/L 
IQF powder(μg/g) 482-1063a  7752-10323
b 
9.8-9.9 
mmol/L 
Lyophilized juice 
(mg/Kg) 0.19  9.84  
(Casedas et al. 
2016) 
a dry weight of cyanidin -3-glucoside equivalent; b dry weight of gallic acid equivalent 
 
4
1
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Table 4: Anthocyanins concentrations across varieties and product presentation. 
Product 
Cyanidin-3-
sophoroside 
  Cyanidin-3-
glucosylrutinoside 
Cyanidin-3-
glucoside 
Cyanidin-3-
rutinoside 
Reference 
Fruit (Italian 
cultivars) (mg/100g) 0.7-2.3 17.3-71.9 0.5-0.9 9.3-25.3 
(Blando et al. 
2004) 
Fruit (Turkish 
cultivars) (mg/100g) 0.48 28.1 1.2 9.2 
(Karaaslan et al. 
2016) 
Juice (German and 
Hungarian cultivars) 
(mg/L) 39-185 361-515  125-213 
(Bonerz et al. 
2007) 
Juice (Turkish 
cultivars) (mg/L) 2.6-21.5 140.3-320.9 2-9.9 35.4-85.5 
(Damar and 
Eksi. 2012) 
Dry (μg/g) 1.9-15.7 11.1-203.6 0.7-7.6 6.9-95.8 
(Kirakosyan et 
al. 2009) 
Lyophilized 
juice(μg/g)  0.08   
(Casedas et al. 
2016) 
 
 
 
 
 
 
4
2
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Table 5: Flavonols profile and concentration in tart cherry products. 
 
 
 
 
 
 
 
 
 
 
 
Flavonol/Unit 
Dry Frozen Concentrate IQF powder Juice  
µg/g µg/g µg/g µg/g mg/L References 
Isorhamnetin rutinoside 35.8-383.1 250.2-328.9 163.7-288.1 62.9-176.6 14-33 
(Kirakosyan et al. 
2009) 
kaempferol 12.9-42.9 3.8-13.1 5.2-11.9 16.8-85.9  
Quercetin 1.9-8.8 5.9-8.5 2.1-6.7 556.2-292.6  
Melatonin nd 2.9-12.3 nd 1.7-7.5  
Quercetin-3-(2-
glucosylrutinoside 
    11-31 
(Bonerz et al. 2007) 
Quercetin-3-rutinoside 
    18-59 
Quercetin-3-glucoside 
    3-8 
Kaemferol-3-rutinoside 
    4-13 43
 
44 
 
Table 6: Phenolic acids profile in tart cherry. 
Sample Neochlorogenic acid  Chlorogenic acid Caffeic acid Author 
Fruit (mg/Kg) 584.7 - 33.3 (Karaaslan et al. 
2016) 
Lyophilized juice 
(mg/Kg) 
1.6 0.6 (Casedas et al. 
2016) 
 
 
Table 7: Nutrient composition of Tart cherry compared to Sweet cherry (values in 100 grams: Adapted from USDA ARS 2017).  
  Sweet cherry Tart Cherry 
Nutrient Unit Value/100 g Value/100 g 
Energy kcal 63 50 
Protein g 1.06 1 
Fiber, total dietary g 2.1 1.6 
Sugars, total g 12.8 8.5 
Minerals mg 267.4 216.4 
Vitamin C, total ascorbic acid mg 7 10 
Thiamin mg 0.03 0.03 
Vitamin A, IU IU 64 128 
Vitamin E (alpha-tocopherol) mg 0.07 0.07 
Vitamin K (phylloquinone) µg 2.1 2.1 
4
4
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ABSTRACT 
Tart cherries have been reported to exert potential health benefits, which has been 
attributed to their specific and abundant polyphenol content. However, there is a need to study the 
impact and fate of tart cherries polyphenols in the gut microbiota. Here, tart cherry, apricots and 
pure polyphenols were submitted to in vitro assays and assessed through to 16S rRNA gene 
sequence sequencing and metabolomics. A short-term dietary intervention study was also 
conducted for microbiota analyses. 
Tart cherry concentrate juices were found to contain expected abundances of anthocyanins 
and flavonols and high amounts of chlorogenic and neochlorogenic acids. Targeted metabolomics 
confirmed that gut microbes were able to degrade those polyphenols, leading to the release mainly 
of 4 hydroxyphenylpropionic acid and to lower amounts of epicatechins and 4-hydroxybenzoic 
acid. Tart cherries were found to induce a large increase of Bacteroides in vitro, likely due to the 
input of polysaccharides, but prebiotic effect was also suggested by Bifidobacterium increase from 
chlorogenic acid. In the human study, two distinct and inverse responses to tart cherry consumption 
were associated with initial levels of Bacteroides. High Bacteroides individuals responded with a 
decrease in Bacteroides and Bifidobacterium, and an increase of Lachnospiraceae, Ruminococcus 
and Collinsella. Low Bacteroides individuals responded with an increase in Bacteroides or 
Prevotella and Bifidobacterium, and a decrease of Lachnospiraceae, Ruminococcus and 
Collinsella. These data confirm that gut microbiota metabolism, in particular the potential 
existence of different metabotypes, needs to be considered in studies attempting to link tart cherries 
consumption and health. 
Keywords: Tart cherry, Apricots; Gut microbiota, Polyphenols; Metabolites. 
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INTRODUCTION 
Tart cherries (Prunus cerasus) are stone fruits from the rosaceae family which have 
become a significant agricultural commodity after centuries of small-scale cultivation [1]. This 
increased popularity is due to: (1) greater resistance to environmental factors than other Prunus 
species [2], (2) improvements in food processing technologies allowing for the production of less 
acidic derived products [3,4] and (3) purported health-promoting properties leading to higher 
customer demand [5,6].  
Tart cherries, like other red-colored fruits [7], contain remarkably high amounts of 
phytochemicals, polyphenols in particular [8-11]. It is well known that plant-derived polyphenols 
possess high antioxidant properties [12,13], and this property has led to extensive research on 
potential health benefits [14-16]. Tart cherries are particularly rich in anthocyanins and flavonols 
like other red-colored fruits [8,17]. A recent study reported that tart cherries may be rich sources 
of chlorogenic (3-caffeoylquinic acid (3-CQA)) and neochlorogenic (5-caffeoylquinic acid (5-
CQA)) acids [18], which have only been described as abundant polyphenols in apricots [19], coffee 
[20] and blueberries [21]. Another study described significant amounts of genistein, an isoflavone 
typically found in soybeans, in certain tart cherry cultivars [22]. Indeed, there have been numerous 
reports of potential health benefits incurred by tart cherries consumption in sport medicine [23,24], 
diabetes and metabolic syndrome [25,26] and cardiovascular health in particular [27-29]. 
However, the antioxidant potential of dietary polyphenols has traditionally been measured 
from the native phenolics extracted from the fruits [30,31]. Only a limited fraction of low 
molecular weight phenolic compounds can be absorbed in the upper intestinal tract, and those 
compounds may have different antioxidant potential than large molecular weight polyphenol 
molecules. It is now well established that polyphenolic molecules undergo biotransformation in 
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the human colon [32-34]. Those metabolic processes are performed by bacterial members of the 
human gut microbiota [35,36]. While ellagitannins bioconversions to urolithins [34] and bacterial 
equol production from isoflavones [37] have been studied extensively; there is limited knowledge 
on how other polyphenols or polyphenol-rich fruits impact the human gut microbiota and it 
metabolic potential [38].  
The objective of this study was to investigate the impact of tart cherries and tart cherry juices on 
the human gut microbiota composition and to determine the fate of polyphenols through 
metabolomics. In vitro fermentations were used to test a variety of cherries and cherry 
concentrates. Because it is known that basal gut microbiota composition strongly drives the 
metabolism of dietary polyphenols [39], a human dietary intervention was also conducted with 
one tart cherry juice concentrate. 
 
MATERIALS AND METHODS 
Materials and reagents 
Plant materials and pure polyphenols 
 
Concentrate juices (King Orchards) of Montmorency tart cherries grown in Michigan were 
provided by the Cherry Marketing Institute. Commercially available tart (Balaton and 
Montmorency tart cherries blend; All Natural) and sweet (Black cherries, Tree of Life) cherry 
concentrate were also used. Fruits of two tart cherries genotypes (Pipacs1 and Érdi bőtermő) 
cultivars harvested in 2010 at the Research and Extension Centre for Fruit Growing (Újfehétró, 
Eastern Hungary), were used in this study. In addition, fruits of two apricot (P. armeniaca L.) 
cultivars (‘Gönci magyarkajszi’ and m604 cultivars) obtained from 2010 vintage of the apricot 
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breeding program conducted at the Department of Genetics and Plant Breeding, Szent István 
University (Budapest) were also evaluated. 
Reagents 
 
Crystalline 3-caffeoylquinic acid (3-CQA), 5-caffeoylquinic acid (5-CQA), rutin, 
kaempferol-rutinoside were purchased from Sigma-Aldrich (St. Louis, USA) and cyanidin-
glucoside from Extrasynthese (Genay, France). Acetonitrile (HPLC Gradient Grade), methanol 
(HPLC Gradient Grade) were obtained from Fisher Scientific (Loughborough, UK) and Sigma-
Aldrich (St. Louis, MO, USA), respectively. Formic acid (98% for mass spectrometry) was 
obtained from Fluka (Sigma-Aldrich). High-purity (18 Mcm-1) water was obtained from a Milli-
Q Plus ultrapure water system from Millipore (Milford, MA, USA). 
 
In vitro digestion experiments 
 
In vitro batch incubations were performed by sampling 25 ml of the distal colon 
compartments from the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). This 
gastrointestinal model is made of five double-jacketed fermentation vessels simulating the 
stomach, small intestine and the three colonic regions conditions [40]. The SHIME was seeded 
with enrichment cultures from human stool samples. Microbial suspensions (25 ml) were placed 
into bottles containing apricots or cherries (5 mL or g) and were incubated for 48 h at 37 °C. To 
maintain anaerobic conditions, l-cysteine (0.5 g/l) was added to bottles before flushing with N2 
during 15 cycles of 2 min each at 800 mbar over pressure and 900 mbar under pressure. Bottles 
were then closed with butyl rubber stoppers and placed at atmospheric pressure. Samples (1 mL 
each) were taken with a syringe and needle at 0, 4, 24 and 48 h. After each sampling, batch cultures 
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were flushed with N2 to maintain anaerobic conditions. Samples were centrifuged (14,000g, for 
10 min at 4 ºC) and pellets and supernatants were stored at −20 °C until further analysis. 
 
Analytical chemistry 
Sample preparation for analytical chemistry 
 
Two hundred µL of fruit juice (Tree of Life, King Orchard or Royal Farms) were diluted to 10 mL 
with methanol: water:formic acid (60:39:1, v/v) and ultrasonicated for 30 min at room temperature 
(< 35 °C at the end). After centrifugation at 3,000g for 10 min, 2.5 mL of the supernatant was 
diluted to 5 mL with water, and filtered through a 0.2 μm PTFE filter (SMI-LabHut Ltd, 
Gloucester, U.K.) before injection on the analytical column for analysis.  
Apricot and cherry fruits were halved after harvesting; stones were removed and stored at -80 °C 
until lyophilization. Lyophilized samples were manually pulverized in a mortar and stored at -20 
°C until dilution of 200 mg into 10mL of methanol: water:formic acid (60:39:1, v/v). Sample 
preparation was then performed as described in the previous paragraph. 
Fluids (from simulated stomach, small and large intestine) of in vitro digestions were 
homogenised after thawing, and 250 µL mixed with 725 µL MeOH containing 1% (v/v) formic 
acid and 25 µL daidzein internal standard (50 µg mL-1). Samples were homogenised for 30 secs 
using a vortex mixer, then centrifuged at 15,000g (10 min, 4°C). After centrifugation, 500 µl 
aliquots of the supernatant were transferred to clean micro-centrifuge tubes and concentrated to 
final volumes below 200 µL with a speed-vacuum. Then 25 µL of MeOH containing 5 % (v/v) 
formic acid was added final volume adjusted to 250 µL with water. Finally, samples were filtered 
through a 0.2 μm PTFE filter before injecting 10 μL on the analytical column for analysis. 
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LC/MS analysis 
 
The LC/MS profiling of fruit juices and in vitro gastric samples were based on the approach 
detailed previously [19,22]. The HPLC system (Agilent 1200, Agilent Technologies, Waldbronn, 
Germany) including a binary pump and a diode array detector (DAD) was coupled to an Agilent 
6350 quadrupole–time-of-flight (Q/TOF) hybrid tandem mass spectrometer (Agilent 
Technologies, Santa Clara, CA USA) equipped with a dual-spray ESI source. Chromatographic 
separation was carried out on a Phenomenex Kinetex Phenyl-hexyl RP (Phenonemex, 
Macclesfield, UK), 4.6 × 150 mm, 2.6 μm particle size column using 0.5% (v/v) formic acid in 
water (mobile phase A) and 0.5% (v/v) formic acid in acetonitrile (mobile phase B) as mobile 
phases at a flow rate of 500 μL/min. The gradient program was started at 8% B and after 5 min of 
isocratic run, solvent B was increased linearly and reached 45 % at 35 min and then 100 % at 40 
min. Finally, 100% B was kept constant for 5 min, followed by 10 min isocratic re-equilibration 
for initial conditions. 
Mass spectrometer was used either in negative or positive ion mode, with the following 
parameters: electrospray capillary voltage, 4000 V; nebulizer pressure, 40 psig; drying gas flow 
rate, 13 L/min; gas temperature, 325 C; skimmer voltage, 65 V. Fragmented voltage was triggered 
automatically between 160 V and 210 V in positive mode and 140 and 240 V in negative mode. 
The instrument performed internal mass calibration automatically, using a reference ESI nebulizer 
with an automated calibrating delivery system, which introduces the flow from the outlet of the 
chromatograph together with a low flow of a calibrating solution. The calibrating solution contains 
internal reference masses of purine and HP-0921 ([hexakis-(1H,1H,3H-tetrafluoropentoxy)-
phosphazene]). Protonated molecules of purine ([C5H5N4]
+ at m/z 121.0509) and HP-0921 
([C18H19O6N3P3F24]
+ at m/z 922.0098) were used as reference masses in positive ion mode, while 
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deprotonated purine at m/z 119.0363 and the formate adduct of HP-0921 ([C19H19O8N3P3F24]
- at 
m/z 966.000725) were used for the same purpose in negative ion mode. 
High resolution (> 20 000 FWHM at m/z 922) full-scan TOF spectra were recorded in the 
range of m/z 50–1100 at a frequency of 1.4 spectra/s. Agilent Mass Hunter Qualitative Analysis 
Software (version B.04.00 build 3.1.346.0) was applied for data evaluation. The DAD acquired 
data in the range of 200-800 nm in 2-nm steps at 0.5 spectra/s acquisition speed.  
 
Quantitative determination of selected polyphenols 
 
Quantitation of chlorogenic acid (3-CQA), neochlorogenic acid (5-CQA), rutin, kaempferol-
rutinoside, was carried out using the standard addition calibration technique and reference 
standards, whereas cyanidin-dH-H-H, Cyanidin-dH-H and cyanidin-glucoside were all quantified 
as cyanidin-glucoside equivalents. Anthocyanins, rutin and kaempferol-rutinoside were quantified 
in positive ion mode using the [M+H] + ion, whereas 3-CQA and 5-CQA were quantified in 
negative ion mode based on their [M-H]- ions.  
 
 Dietary intervention 
 
The study was approved by the University of Arkansas IRB (IRB# 15-02-476). A cohort 
of 10 healthy participants of five of each gender from 23 to 30 years old were recruited. All 
individuals took part in a screening session where they signed a consent form and completed a 
Food Frequency Questionnaire (FFQ). The individuals where generally healthy, with normal 
digestive function, non-smokers, and had not consumed any type of antibiotics for twelve weeks 
prior and during the intervention Each individual received tart cherry concentrate (King Orchard, 
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provided by the Cherry Marketing Institute) for the length of the study. Subjects were instructed 
to consume 8 oz of juice daily for five days. Additionally, they received a stool collection kit 
(commode Specimen Collection System; Fisher Scientific, Pittsburg, PA, USA) and provided a 
stool samples before and after the dietary intervention. Once the samples were collected they were 
stored at -80°C until analysis.  
Microbial Analyses 
DNA extraction 
 
Bacterial DNA was extracted and purified from the stool samples with the QIAamp Fast 
DNA Stool Mini Kit (Qiagen, Valencia, CA) following the manufacturer’ recommendations with 
addition of an initial bead-beading step (autoclaved 100 mg of 0.1 mm and 0.5 mm diameter 
Zirconia-silicate beads - BioSpec Products) for 30 s at 30 Hz repeated 3 times using FastPrep-24 
sample preparation system (MP Biomedical, CA) [41]. The genomic DNA quantification was 
measured with a Qubit Fluorometer (Life Technologies, Carlsbad, CA).  A polymerase chain 
reaction (PCR) was set up in a 96 well plate for confirmation of the bacterial DNA quality with 
universal 8F and 1541R primers for bacteria [42]. The quality was checked with 12% of samples 
randomly selected on a gel electrophoresis of 1% agarose gel to ensure amplification was normal 
and verify the presence of bacterial DNA from the stool sample [43]. 
Library Preparation for sequencing 
 
After bacterial DNA quality check, a second polymerase chain reaction (PCR) was 
performed to amplify the V4 region of the 16S rRNA gene using dual-indexed Illumina primers 
[43]. PCR reaction mixtures were set up with Accuprime Pfx SuperMix (Life Technologies, 
Carlsbad, CA) according to the manufacturer’s protocol, forward and reverse primers (200nM final 
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concentration) and template DNA (15 ng) in a 96 well plate; each plate contained a negative control 
(water). The amplification was carried out in an Eppendorf Mastercycler pro S (Eppendorf) under 
the following conditions 95°C for 5 min for initiation with 30 cycles of thermal program 
(denaturation, 95°C for 30 s; annealing, 55°C for 30 s; extension, 72°C for 60 s) and finally 72°C 
for 5 min. Then all samples were run in a 1% gel electrophoresis at 100v for 40 min for quality 
control of the PRC product.  
Normalization and purification of the amplicon was performed using Invitrogen 
SequalPrep Kit (Life Technologies, Carlbad, CA) following the manufacturer’s recommendations 
in order to remove residual salts or short oligonucleotide primers and normalize the concentration. 
To ensure success of the step a 1% gel electrophoresis was run with all the samples. Then, aliquots 
of 5 μL of each sample were pooled together. Pooled samples quality was checked on a 
TapeStation (Agilent). Real-time quantitative PCR was performed using Eppendorf Realplex 
Mastercycler ep gradient S (Eppendorf, Hamburg, Germany) using the PerfeCta NGS library 
Quantification Kit (Quanta Biosiences, Beverly, MA) according to the manufacturer’s protocol.  
The prepared library was mixed and diluted with 0.2 N NaOH and HT1 buffer, along with 
the control mix of PhiX control V4 and both solutions brought up to 8 pM of final concentration. 
The diluted amplicon and control were combined and loaded to the Illumina Miseq reagent 
cartridge along to the index, read 1 and read 2 sequencing primers. 
Sequence and Statistical Analysis 
 
 The sequencing reads were downloaded from the Illumina Basespace server in Fastq files 
format. The sequences were demultiplexed in read 1 and read 2 with approximately 250bp in 
length. The sequencing analyses were carried out using SILVA database as reference for 
55 
 
assignation of operational taxonomic units (OTUs) with 97% of identity. Further analysis was done 
using Mothur 1.35.1 pipeline [44]. Non-metric multidimensional scaling (NMDS) plots and 
analysis of similarities (ANOSIM), both based on the Bray-Curtis index, were obtained in PAST 
3.15. In addition, Kruskal Wallis and Mann-Whitney tests were performed to detect significant 
differences in bacterial taxa between samples and time points (by convention, differences were 
considered significant when p<0.05). 
RESULTS AND DISCUSSION 
Tart cherry juices phenolic profiles 
 
To the best of our knowledge, this is the first time that concentrated juices of Montmorency 
and Balaton tart cherries grown in the U.S. were profiled for their phenolic content. In comparison 
with previous studies on sweet cherries or European sour cherries, profiles were similar in the 
composition of anthocyanins, hydroxycinnamic acids and flavonols (Table 1) [4,17,45,46]. The 
most notable difference was the absence of detection of catechins and epicatechins which were 
reported in European sour cherries cultivars. While anthocyanins have received more attention for 
tart cherries, we report here that the most abundant polyphenols in the concentrated juices were 
the hydroxycinnamic acids: chlorogenic (3-CQA) and neochlorogenic (5-CQA) acids (Table 1). 
Remarkably, 3-CQA, but not 5-CQA was much less abundant in the sweet cherry concentrated 
juice. The only other food containing high levels of 3-CQA are coffee [20,47,48], apricots [49] 
and blueberries [21].  
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Polyphenol degradation and associated phenolic metabolites in vitro 
 
As expected, in the initial stages (stomach and small intestine SHIME compartments), 3-
CQA, quercetin-3-O rutinoside and glucoside, and kaempferol-rutinoside were among the most 
abundant polyphenols. However, metabolomics also revealed the presence of significant amounts 
of catechin and epicatechin in tart cherry concentrates only, indicating that tart cherry contained 
tannins (Figure 1A). Somewhat surprisingly, the concentration of those polyphenols decreased 
significantly in the stomach and small intestine. The concentration of all the detected native 
polyphenols declined steadily with time in the colonic fermentation, confirming that resident 
microbiota was responsible for their bioconversion. 
3-CQA catabolism was somewhat constant during the 48 hr of fermentation. 3-CQA 
derivatives included caffeic acid at very low concentrations, but the main metabolite was dihydro-
coumaric acid (Figure 1B) as described before [50,51].In the early stages of the SHIIME 
experiment, large amounts of 4-hydroxyphenylacetic acid were detected and decreased to stable 
amounts in the colon compartment (Supplementary Figure 1), which makes it difficult to assess if 
this metabolite originates from bacterial metabolism. However, this metabolite is known to derive 
from quercetin and kaempferol from different berries [52]. At this point, very small amounts of 
quercetin-3-O-glucoside were detected compared with quercetin-3-O-rutinoside and kaempferol-
3-O-rutinoside that were still present at higher concentrations. The rutinoside derivatives 
concentrations decreased subsequently, suggesting that gut microbes preferentially used the 
glucoside forms before the rutinosides. Quercetin was apparently converted to 3,4 and 4-
hydroxybenzoic acid, but catechins may represent another origin for these metabolites (Figure 1B), 
as both pathways have been described [53].  
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Impact of tart cherries and apricots on gut microbiota in vitro 
 
A total of 68 samples were subjected to DNA extraction and sequencing (replicate samples 
derived from concentrated juices and control were also sequenced due to low read counts in the 
first sequencing run). Overall 202,239 high quality reads (2974±1760) were obtained, 192,459 
(3262±1700) when excluding low read (<1,500) counts. 
The control fermentation with only stool samples yielded a low diversity microbiota dominated by 
Verrumicrobia then Synergistes (Figure 2A), two marginal phyla in the human colon. Remarkably, 
the two major genera present in the control fermentation, Akkermansia and Cloacibacillus 
(Supplementary Figure 2) are well known for their strict metabolism of feeding from host-derived 
mucins rather than dietary elements in the lumen [54-56]. In addition, Bifidobacterium 
(Actinobacteria), present in relatively high abundance, have also been shown to be able to feed on 
host mucins [57,58], and the third most abundant genera, Bilophila, is able to metabolize host bile 
acids [59,60]. It appears that fermentation of dietary elements present in the batch cultures was 
primarily conducted by Bacteroides and several members of the Firmicutes in succession 
(Veillonella (0hr), then Lachnospiraceae (4-24 hr) and Lachnospiraceae, Eubacteriaceae and 
Clostridium XIVa (48 hr). Somewhat surprisingly, some genera typically present in high 
abundance and known as polysaccharides and fiber fermenters [61-63] were detected in marginal 
relative abundance (though it does not mean they were not active), in particular Prevotella and 
Ruminococcus. 
As expected, fermentation with polyphenols and to a greater extent with fruit matrices significantly 
shifted the microbiota, primarily with a dramatic and consistent decrease in Verrumicrobia then 
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Synergistes and increase in Bacteroidetes primarily, and to a lesser extent Firmicutes and 
Proteobacteria (Figure 2B-D). 
Impact of tart cherries powder and tart cherries concentrated juices 
 
All tart and sweet cherries products lead to similar gut microbiota modulation (Figure 3A), 
driven by very significant increase of Bacteroides relative abundance at all time-points (Figure 
3B), probably reflecting fermentation of sugars and carbohydrates which are the main energy 
source for Bacteroides [64]. Other genera that were significantly increased included Veillonella, 
Bilophila Enterobacteriaceae and Escherichia and Clostridium XIVa. These dynamics probably 
reflects carbohydrates fermentation rather than plolyphenols biotransformation.  
Similar trends were observed for sweet cherry juice (Supplementary Figure 2), however the 
increase in Bacteroides was less marked, and Clostridium XIVa, Lachnospiraceae and 
Eubacteriaceae increased slightly, presumably because of the higher sugar and polysaccharides 
content of this juice. 
Impact of apricot powder on the gut microbiota 
 
Apricots have been shown to contain high amounts of 3-CQA, and to be generally rich in 
a diversity of polyphenols [19,49]. Two apricot varieties were subjected to in vitro fermentation 
and induce a very significant modulation of the gut microbiota (Figure 4A). As with tart cherries, 
apricots fermentation resulted in an overwhelming increase of Bacteroidetes (Figure 1B), 
Bacteroides in particular (Figure 4B). Remarkably, and in contrast with tart cherries, a significant 
increase of Lactobacillales, Lactobacillaceae and Lactobacillus (around 15%) was observed after 
48 hours of fermentation. While Lactobacillus has been identified as able to metabolize 3-CQA 
[66], this is to the best of our knowledge the first time that a very strong potential prebiotic impact 
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is suggested for apricots. However, it should be reminded that 48 hours in vitro fermentation may 
not really be representative of in vivo metabolism, and thus further analyses with apricots would 
be needed. 
Impact of representative pure polyphenols 
 
Since the microbiota in cherries’ batch fermentation were likely more influenced by 
nutrient than polyphenol content, representative polyphenols were subjected to similar 
fermentation to better determine their potential impact on human gut microbiota. Indeed, gut 
microbiota dynamics was different in terms of abundance (Figure 5), but with similar responsive 
taxa. 
As confirmed by our concentrated juices’ polyphenols profiling, tart cherries are 
particularly rich in 3-CQA and 5-CQA yielded a notable increase in Bifidobacterium in the first 
three time-points (Supplementary Figure 7), which is in accordance with previous reports of 
Bifidobacterium species’ ability to catabolize CA [48,67,68]. However, these studies also reported 
Lactobacillus species as common CA degraders [69], while in our case there was no visible change 
in Lactobacillus and other lactic acid bacteria (if anything, there was often a very slight decrease). 
Other taxa stimulated included Bacteroides to a small extent, Bilophila, Veillonella and members 
of the Clostridium XIVa cluster. The latter observation lines up with the report of increased 
Clostridium coccoides-Eubacterium rectale group by pure 3-CQA [48]. Bacteroides has been 
reported as a primary degrader of complex carbohydrates that are used as source of energy [64]. 
The stimulation of Veillonella and Bilophila is more enigmatic. As a lactate fermenter [70,71], the 
increase of Veillonella may be explained by cross-feeding on lactate produced by Bifidobacterium, 
however lactate production has only been shown from oligosaccharides in Bifidobacterium [72]. 
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Bilophila is known to ferment polysaccharides with taurine or hydrogen as final eletron acceptors 
[73]. It is thus possible that Bilophila disposes of the hydrogen released through fermentation of 
dietary molecules, a process that would likely be performed by other hydrogenotrophic bacteria 
and archaea in vivo [74,75]. 
Quercetin-rutinoside (QR) was the second most abundant polyphenol in concentrated tart 
cherry juices. Somewhat similarly to, QR led to an increase in Bacteroides, Bifidobacterium, 
Veillonella and Bilophila (Supplementary Figure 8). The most notable difference was a strong 
increase in members of Clostridium cluster XIVa with a peak at 4hr, mirroring the Bifidobacterium 
dynamics. It seems likely that Clostridium XIVa cross-feed on rutinoside derived from 
Bifidobacterium [76,77] and possibly Bacteroides breakdown of QR, while Bilophila disposed of 
hydrogen produced by this fermentation. 
To the best of our knowledge, cyanidin rutinoside impact on human gut microbiota was 
never tested before. Cyanidin rutinoside resulted in a marked increase of Bacteroides, but limited 
bifidogenic effect (Supplementary Figure 8). Veillonella and Clostridium XIVa were again 
stimulated as well as Bilophila, presumably because of similar metabolic requirements and 
properties as described for QR. 
While genistein was not measured in the tart cherry concentrates, its abundance has been 
shown in other tart cherry cultivars [22]. Genistein (Supplementary Figure 9) induced a significant 
bifidogenic effect as well as increases of Collinsella and Assacharobacter, which have been 
reported as degraders of isoflavones that do not produce equol [78]. 
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Since Bifidobacterium relative numbers were not affected in contrast with other mucin degraders, 
we can hypothesize that polyphenols in tart cherries and concentrates were to a certain extent 
metabolized by Bifidobacterium. 
Impact of tart cherries on gut microbiota in vivo 
 
One individual’s sample yielded very low read counts, and thus sequences from nine subjects 
were analyzed. A total number of 124,172 high quality reads (6898±2455) were obtained. When 
comparing all individuals before and after dietary intervention, very little difference in microbiota 
was observed (Supplementary Figure 10). However, it was found that individuals initial microbiota 
were highly variable, with the relative abundances of Bacteroides being the main driver. Since 
Bacteroides was the genus primarily impacted by concentrated juice in vitro, it was decided to 
split the individuals in two groups: low (<10%; n= 4; LB) and high (>20%; n= 5; HB) Bacteroides 
in the initial gut microbiota (it should be noted that no individual exhibited relative abundance 
between 10 and 20%). Separating human cohorts according to their enterotypes [79,80] or 
metabotypes [39,81] is an increasingly common approach to overcome the inherent interindividual 
variability in gut microbiota profiles. Here, we observed that the microbiota were significantly 
different (ANOSIM: p<0.05) before and after dietary intervention among both groups (Figure 6) 
In addition, the grouping revealed significant differences in dietary habits, with higher intake of 
carbohydrates, sugar and fibers associated with LB (and high Firmicutes) gut microbiota (Table 
2). LB individuals also tended to have lower BMI. 
At the phylum level, the HB group initially had higher Bacteroidetes than the LB, and LB had 
more Firmicutes. In the HB group, tart cherry consumption resulted in a sharp significant decrease 
of Bacteroides, Parabacteroides and Alistipes, as well as suggestive decrease of the low abundant 
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Barnesiella, Butyricimonas, Odoribacter, Porphyromonas and other Prevotellaceae (Figure 7A). 
These trends were mirrored with significant or suggestive increases in many Firmicutes 
(Ruminococcus, Lachnospiraceae, Clostridium and Clostridium XI, Dialister, Coprococcus, 
Lactobacillus and Streptococcus), with the notable exception of a significant decrease in 
Faecalibacterium relative abundance. Somewhat surprisingly, Bifidobacterium numbers tended to 
decrease, but a significant increase in other Actinobacteria and Collinsella was observed. 
Remarkably, the dynamics were almost completely opposite in the LB group (Figure 7B). All 
abundant Bacteroidetes genera increased though generally only in a suggestive manner. In 
particular it should be noted that the apparent increases in Prevotella for each group was entirely 
driven by one individual in each group increasing from less than 1% to more than 15%. Prevotella 
is considered a major genus in driving “enterotypes”, and has been consistently associated with 
consumption of plant-rich diets [82-86]. More specifically, it was shown that short-term dietary 
intervention with “extreme” plant-based diets can drive strong Prevotella expansion, with 
responsiveness varying greatly between individuals [62], in agreement with our findings. The 
increase in Bacteroidetes genera was mirrored with decreases in some Firmicutes members 
(Lachnospiraceae, Streptococcus, Dialister, Blautia and Roseburia), however, increase in 
Clostridium IV and XI, Subdoligranulum and Lactobacillus (numerical) were also observed. 
Bifidobacterium relative abundance increased numerically, associated with significant decrease in 
Collinsella and suggestive decrease in Assacharobacter and other Actinobacteria. Therefore, the 
only common response for the HB and LB were a maintenance or slight increase of Ruminococcus 
and a sharp decrease of Faecalibacterium. Ruminococcus are well known to degrade complex 
polysaccharides (cellulose, xylan, pectins…) and dietary fibers in the human colon [61,63], while 
Faecalibacterium has been particularly associated with high fiber consumption [87-89]. Since tart 
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cherry juice contains no dietary fiber, these trends may be due to lower dietary fiber intake by the 
subjects during the dietary intervention, because of the important fruit intake through juice 
consumption. Since the HB group had lower regular intake of carbohydrates, it is likely that the 
large intake of complex polysaccharides stimulated Lachnospiraceae and other Clostridiales 
typically involved in the metabolism of those molecules [90-92]. It appears that in HB individuals, 
high 3-CQA and 5CQA intake selected more Collinsella than Bifidobacterium, bringing more 
evidence for Collinsella’s potential role in polyphenol degradation. The LB group response was 
more in line with the In vitro dynamics, indicating that the donor(s) gut microbiota was likely 
similar. It can be hypothesized that the LB response is more driven by the high polyphenol intake, 
since their gut microbiota was presumably adapted to higher complex polysaccharides intake. The 
increases in Bacteroides and Bifidobacterium would then be explained by their known abilities to 
metabolize 3-CQA, 5-CQA and many polyphenols present in tart cherries [93-97]. Based on 
previous studies [66,98], a significant increase may have been expected in Lactobacillus, however 
Lactobacillus were, surprisingly, not prevalent and abundant in this human cohort.  
 
CONCLUSIONS 
To the best of our knowledge, this study represents the first microbiota/metabolome 
investigation of the impact and fate of tart cherries and their polyphenols in the human colon. The 
metabolomics from in vitro fermentation showed that 3-CQA and 5-CQA, the dominant 
polyphenols, were mainly converted to dihydrocoumaric acid. In vitro fermentation of tart cherry 
powder and concentrated juices (and apricots) resulted in large increases in Bacteroides and 
Collinsella and moderate increases of specific Firmicutes, Enterobacteriaceae and Bilophila. In 
vitro fermentation of pure polyphenols indicated bifidogenic effects for 3-CQA and 5-CQA, 
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genistin and to a lesser extent rutin and cyanidin. Bacteroides appeared to be more involved in 
rutin and cyanidin metabolism. The human dietary intervention demonstrated strikingly different 
responses due to initial microbiota composition, apparently driven by individuals’ habitual 
consumption of carbohydrates and fiber. The high Bacteroides group (low carbohydrates and fiber) 
responded to tart cherry juice consumption with decrease of Bacteroides and increase of 
fermentative Firmicutes and potential polyphenol metabolizer Collinsella. The low Bacteroides 
group responded with an increase in Bacteroides and Bifidobacterium (presumably due largely to 
polyphenols availability) and decrease in in the relative abundance of fermentative Firmicutes. 
Overall, our results confirm that gut microbiota strongly influences polyphenol metabolites 
from polyphenol-rich tart cherries in the human colon. Further, the data suggests that gut 
microbiota of individuals consuming a more Western diet may have lower ability to metabolize 
polyphenols, thereby reducing bioavailability and any potential health benefits.  
 
ACKNOWLEDGMENTS 
In vitro and in vivo gut microbiota analyses of tart cherries were funded by a research grant from 
the Cherry Marketing Institute to FC, SOL and LH. Metabolome analyses were performed by NP 
and LA in exchange for microbiota analyses of their apricots and cherries.  
65 
 
REFERENCES 
[1] Brown-Skrobot SK, Way RD, Terry DE. Sweet and tart cherry varieties: descriptions and 
cultural recommendations. Geneva, N.Y.: New York State Agricultural Experiment Station; 
1989. 
[2] Swinton SM, Scorsone EA. Short-term costs and returns to Michigan apple, blueberry, and 
tart cherry enterprises with reduced pesticide availability. ; 1997. 
[3] Zoric Z, Pedisic S, Kovacevic DB, Jezek D, Dragovic-Uzelac V. Impact of packaging 
material and storage conditions on polyphenol stability, colour and sensory characteristics of 
freeze-dried sour cherry (prunus cerasus var. Marasca). J Food Sci Technol. 2016;53:1247-1258. 
[4] Ou B, Bosak KN, Brickner PR, Iezzoni DG, Seymour EM. Processed tart cherry products--
comparative phytochemical content, in vitro antioxidant capacity and in vitro anti-inflammatory 
activity. J Food Sci. 2012;77:H105-12. 
[5] Bell PG, McHugh MP, Stevenson E, Howatson G. The role of cherries in exercise and health. 
Scand J Med Sci Sports. 2014;24:477-490. 
[6] Traustadottir T, Davies SS, Stock AA, Su Y, Heward CB, Roberts LJ,2nd, Harman SM. Tart 
cherry juice decreases oxidative stress in healthy older men and women. J Nutr. 2009;139:1896-
1900. 
[7] Chen L, Xin X, Yuan Q, Su D, Liu W. Phytochemical properties and antioxidant capacities 
of various colored berries. J Sci Food Agric. 2013. 
[8] Blando F, Gerardi C, Nicoletti I. Sour Cherry (Prunus cerasus L) Anthocyanins as Ingredients 
for Functional Foods. J Biomed Biotechnol. 2004;2004:253-258. 
[9] Cao J, Jiang Q, Lin J, Li X, Sun C, Chen K. Physicochemical characterisation of four cherry 
species (Prunus spp.) grown in China. Food Chem. 2015;173:855-863. 
[10] Schuller E, Halbwirth H, Mikulic-Petkovsek M, Slatnar A, Veberic R, Forneck A, Stich K, 
Spornberger A. High concentrations of anthocyanins in genuine cherry-juice of old local 
Austrian Prunus avium varieties. Food Chem. 2015;173:935-942. 
[11] Wojdylo A, Nowicka P, Laskowski P, Oszmianski J. Evaluation of sour cherry (Prunus 
cerasus L.) fruits for their polyphenol content, antioxidant properties, and nutritional 
components. J Agric Food Chem. 2014;62:12332-12345. 
[12] Moyer RA, Hummer KE, Finn CE, Frei B, Wrolstad RE. Anthocyanins, phenolics, and 
antioxidant capacity in diverse small fruits: vaccinium, rubus, and ribes. J Agric Food Chem. 
2002;50:519-525. 
66 
 
[13] Pellegrini N, Serafini M, Colombi B, Del Rio D, Salvatore S, Bianchi M, Brighenti F. Total 
antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three 
different in vitro assays. J Nutr. 2003;133:2812-2819. 
[14] Montrose DC, Horelik NA, Madigan JP, Stoner GD, Wang LS, Bruno RS, Park HJ, 
Giardina C, Rosenberg DW. Anti-inflammatory effects of freeze-dried black raspberry powder in 
ulcerative colitis. Carcinogenesis. 2011;32:343-350. 
[15] Blumberg JB, Camesano TA, Cassidy A, Kris-Etherton P, Howell A, Manach C, Ostertag 
LM, Sies H, Skulas-Ray A, Vita JA. Cranberries and their bioactive constituents in human 
health. Adv Nutr. 2013;4:618-632. 
[16] Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary 
(poly)phenolics in human health: structures, bioavailability, and evidence of protective effects 
against chronic diseases. Antioxid Redox Signal. 2013;18:1818-1892. 
[17] Crupi P, Genghi R, Antonacci D. In-time and in-space tandem mass spectrometry to 
determine the metabolic profiling of flavonoids in a typical sweet cherry (Prunus avium L.) 
cultivar from Southern Italy. J Mass Spectrom. 2014;49:1025-1034. 
[18] Casedas G, Les F, Gomez-Serranillos MP, Smith C, Lopez V. Bioactive and functional 
properties of sour cherry juice (Prunus cerasus). Food Funct. 2016;7:4675-4682. 
[19] Nagy A, Abranko L. Profiling of hydroxycinnamoylquinic acids in plant extracts using in-
source CID fragmentation. J Mass Spectrom. 2016;51:1130-1145. 
[20] Renouf M, Marmet C, Giuffrida F, Lepage M, Barron D, Beaumont M, Williamson G, 
Dionisi F. Dose-response plasma appearance of coffee chlorogenic and phenolic acids in adults. 
Mol Nutr Food Res. 2014;58:301-309. 
[21] Cho MJ, Howard LR, Prior RL, Clark JR. Flavonoid glycosides and antioxidant capacity of 
various blackberry, blueberry and red grape genotypes determined by high-performance liquid 
chromatography/mass spectrometry. J Sci Food Agric. 2004;84:1771-1782. 
[22] Abranko L, Nagy A, Szilvassy B, Stefanovits-Banyai E, Hegedus A. Genistein isoflavone 
glycoconjugates in sour cherry (Prunus cerasus L.) cultivars. Food Chem. 2015;166:215-222. 
[23] Bell PG, Walshe IH, Davison GW, Stevenson EJ, Howatson G. Recovery facilitation with 
Montmorency cherries following high-intensity, metabolically challenging exercise. Appl 
Physiol Nutr Metab. 2015;40:414-423. 
[24] Bell PG, Walshe IH, Davison GW, Stevenson E, Howatson G. Montmorency cherries 
reduce the oxidative stress and inflammatory responses to repeated days high-intensity stochastic 
cycling. Nutrients. 2014;6:829-843. 
67 
 
[25] Lachin T. Effect of antioxidant extract from cherries on diabetes. Recent Pat Endocr Metab 
Immune Drug Discov. 2014;8:67-74. 
[26] Papp N, Blazovics A, Febel H, Salido S, Altarejos J, Feher E, Kocsis I, Szentmihalyi K, 
Abranko L, Hegedus A, Stefanovits-Banyai E. Antihyperlipidemic Effects of Sour Cherries 
Characterized by Different In Vitro Antioxidant Power and Polyphenolic Composition. Plant 
Foods Hum Nutr. 2015;70:408-413. 
[27] Csiki Z, Papp-Bata A, Czompa A, Nagy A, Bak I, Lekli I, Javor A, Haines DD, Balla G, 
Tosaki A. Orally delivered sour cherry seed extract (SCSE) affects cardiovascular and 
hematological parameters in humans. Phytother Res. 2015;29:444-449. 
[28] Juhasz B, Kertesz A, Balla J, Balla G, Szabo Z, Bombicz M, Priksz D, Gesztelyi R, Varga 
B, Haines DD, Tosaki A. Cardioprotective effects of sour cherry seed extract (SCSE) on the 
hypercholesterolemic rabbit heart. Curr Pharm Des. 2013;19:6896-6905. 
[29] Keane KM, Haskell-Ramsay CF, Veasey RC, Howatson G. Montmorency Tart cherries 
(Prunus cerasus L.) modulate vascular function acutely, in the absence of improvement in 
cognitive performance. Br J Nutr. 2016;116:1935-1944. 
[30] Martin KR, Wooden A. Tart cherry juice induces differential dose-dependent effects on 
apoptosis, but not cellular proliferation, in MCF-7 human breast cancer cells. J Med Food. 
2012;15:945-954. 
[31] Shukitt-Hale B, Kelly ME, Bielinski DF, Fisher DR. Tart Cherry Extracts Reduce 
Inflammatory and Oxidative Stress Signaling in Microglial Cells. Antioxidants (Basel). 
2016;5:10.3390/antiox5040033. 
[32] Etxeberria U, Fernandez-Quintela A, Milagro FI, Aguirre L, Martinez JA, Portillo MP. 
Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J 
Agric Food Chem. 2013;61:9517-9533. 
[33] Faria A, Fernandes I, Norberto S, Mateus N, Calhau C. Interplay between anthocyanins and 
gut microbiota. J Agric Food Chem. 2014;62:6898-6902. 
[34] Garcia-Munoz C, Vaillant F. Metabolic fate of ellagitannins: implications for health, and 
research perspectives for innovative functional foods. Crit Rev Food Sci Nutr. 2014;54:1584-
1598. 
[35] Duenas M, Cueva C, Munoz-Gonzalez I, Jimenez-Giron A, Sanchez-Patan F, Santos-Buelga 
C, Moreno-Arribas MV, Bartolome B. Studies on Modulation of Gut Microbiota by Wine 
Polyphenols: From Isolated Cultures to Omic Approaches. Antioxidants (Basel). 2015;4:1-21. 
[36] Jimenez-Giron A, Queipo-Ortuno MI, Boto-Ordonez M, Munoz-Gonzalez I, Sanchez-Patan 
F, Monagas M, Martin-Alvarez PJ, Murri M, Tinahones FJ, Andres-Lacueva C, Bartolome B, 
Moreno-Arribas MV. Comparative study of microbial-derived phenolic metabolites in human 
68 
 
feces after intake of gin, red wine, and dealcoholized red wine. J Agric Food Chem. 
2013;61:3909-3915. 
[37] Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr. 2010;140:1355S-
62S. 
[38] Etxeberria U, Fernandez-Quintela A, Milagro FI, Aguirre L, Martinez JA, Portillo MP. 
Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J 
Agric Food Chem. 2013;61:9517-9533. 
[39] Bolca S, Van de Wiele T, Possemiers S. Gut metabotypes govern health effects of dietary 
polyphenols. Curr Opin Biotechnol. 2013;24:220-225. 
[40] Van den Abbeele P, Grootaert C, Marzorati M, Possemiers S, Verstraete W, Gerard P, 
Rabot S, Bruneau A, El Aidy S, Derrien M, Zoetendal E, Kleerebezem M, Smidt H, Van de 
Wiele T. Microbial community development in a dynamic gut model is reproducible, colon 
region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ 
Microbiol. 2010;76:5237-5246. 
[41] Zoetendal EG, Heilig HG, Klaassens ES, Booijink CC, Kleerebezem M, Smidt H, de Vos 
WM. Isolation of DNA from bacterial samples of the human gastrointestinal tract. Nat Protoc. 
2006;1:870-873. 
[42] Carbonero F, Oakley BB, Purdy KJ. Metabolic flexibility as a major predictor of spatial 
distribution in microbial communities. PLoS One. 2014;9:e85105. 
[43] Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-
index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the 
MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013. 
[44] Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, 
Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 
Introducing mothur: open-source, platform-independent, community-supported software for 
describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537-7541. 
[45] Damar I, Eksi A. Antioxidant capacity and anthocyanin profile of sour cherry (Prunus 
cerasus L.) juice. Food Chem. 2012;135:2910-2914. 
[46] Diaz-Garcia MC, Obon JM, Castellar MR, Collado J, Alacid M. Quantification by UHPLC 
of total individual polyphenols in fruit juices. Food Chem. 2013;138:938-949. 
[47] Lopez-Barrera DM, Vazquez-Sanchez K, Loarca-Pina MG, Campos-Vega R. Spent coffee 
grounds, an innovative source of colonic fermentable compounds, inhibit inflammatory 
mediators in vitro. Food Chem. 2016;212:282-290. 
69 
 
[48] Mills CE, Tzounis X, Oruna-Concha MJ, Mottram DS, Gibson GR, Spencer JP. In vitro 
colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal 
microbiota growth. Br J Nutr. 2015;113:1220-1227. 
[49] Dragovic-Uzelac V, Levaj B, Mrkic V, Bursac D, Boras M. The content of polyphenols and 
carotenoids in three apricot cultivars depending on stage of maturity and geographical region. 
Food Chemistry. 2007;102:966-975. 
[50] Gonthier MP, Remesy C, Scalbert A, Cheynier V, Souquet JM, Poutanen K, Aura AM. 
Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human 
faecal microbiota in vitro. Biomed Pharmacother. 2006;60:536-540. 
[51] Williamson G, Clifford MN. Role of the small intestine, colon and microbiota in 
determining the metabolic fate of polyphenols. Biochem Pharmacol. 2017. 
[52] Khanal R, Howard LR, Prior RL. Urinary excretion of phenolic acids in rats fed cranberry, 
blueberry, or black raspberry powder. J Agric Food Chem. 2014;62:3987-3996. 
[53] Clifford MN, van der Hooft JJ, Crozier A. Human studies on the absorption, distribution, 
metabolism, and excretion of tea polyphenols. Am J Clin Nutr. 2013;98:1619S-1630S. 
[54] Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. 
nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54:1469-
1476. 
[55] Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. The Mucin degrader 
Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ 
Microbiol. 2008;74:1646-1648. 
[56] Looft T, Levine UY, Stanton TB. Cloacibacillus porcorum sp. nov., a mucin-degrading 
bacterium from the swine intestinal tract and emended description of the genus Cloacibacillus. 
Int J Syst Evol Microbiol. 2013;63:1960-1966. 
[57] Turroni F, Milani C, van Sinderen D, Ventura M. Genetic strategies for mucin metabolism 
in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut 
Microbes. 2011;2:183-189. 
[58] Ruas-Madiedo P, Gueimonde M, Fernandez-Garcia M, de los Reyes-Gavilan CG, Margolles 
A. Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota. 
Appl Environ Microbiol. 2008;74:1936-1940. 
[59] Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos 
DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and 
colitis in Il10-/- mice. Nature. 2012;487:104-108. 
70 
 
[60] Baron EJ, Summanen P, Downes J, Roberts MC, Wexler H, Finegold SM. Bilophila 
wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from 
appendicitis specimens and human faeces. J Gen Microbiol. 1989;135:3405-3411. 
[61] Ben David Y, Dassa B, Borovok I, Lamed R, Koropatkin NM, Martens EC, White BA, 
Bernalier-Donadille A, Duncan SH, Flint HJ, Bayer EA, Morais S. Ruminococcal cellulosome 
systems from rumen to human. Environ Microbiol. 2015;17:3407-3426. 
[62] Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T, Hallen A, 
Martens E, Bjorck I, Backhed F. Dietary Fiber-Induced Improvement in Glucose Metabolism Is 
Associated with Increased Abundance of Prevotella. Cell Metab. 2015;22:971-982. 
[63] Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the 
degradation of resistant starch in the human colon. ISME J. 2012;6:1535-1543. 
[64] Comstock LE. Importance of glycans to the host-bacteroides mutualism in the mammalian 
intestine. Cell Host Microbe. 2009;5:522-526. 
[65] Barroso E, Munoz-Gonzalez I, Jimenez E, Bartolome B, Moreno-Arribas MV, Pelaez C, 
Del Carmen Martinez-Cuesta M, Requena T. Phylogenetic profile of gut microbiota in healthy 
adults after moderate intake of red wine. Mol Nutr Food Res. 2017;61:10.1002/mnfr.201600620. 
Epub 2016 Nov 30. 
[66] Ludwig IA, Paz de Pena M, Concepcion C, Alan C. Catabolism of coffee chlorogenic acids 
by human colonic microbiota. Biofactors. 2013;39:623-632. 
[67] Couteau D, McCartney AL, Gibson GR, Williamson G, Faulds CB. Isolation and 
characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol. 
2001;90:873-881. 
[68] Raimondi S, Anighoro A, Quartieri A, Amaretti A, Tomas-Barberan FA, Rastelli G, Rossi 
M. Role of bifidobacteria in the hydrolysis of chlorogenic acid. Microbiologyopen. 2015;4:41-
52. 
[69] Palocz O, Paszti-Gere E, Galfi P, Farkas O. Chlorogenic Acid Combined with Lactobacillus 
plantarum 2142 Reduced LPS-Induced Intestinal Inflammation and Oxidative Stress in IPEC-J2 
Cells. PLoS One. 2016;11:e0166642. 
[70] Washio J, Shimada Y, Yamada M, Sakamaki R, Takahashi N. Effects of pH and lactate on 
hydrogen sulfide production by oral Veillonella spp. Appl Environ Microbiol. 2014;80:4184-
4188. 
[71] Hinton A,Jr, Hume ME. Synergism of lactate and succinate as metabolites utilized by 
Veillonella to inhibit the growth of Salmonella typhimurium and Salmonella enteritidis in vitro. 
Avian Dis. 1995;39:309-316. 
71 
 
[72] Davis LM, Martinez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals 
that consumption of galactooligosaccharides results in a highly specific bifidogenic response in 
humans. PLoS One. 2011;6:e25200. 
[73] da Silva SM, Venceslau SS, Fernandes CL, Valente FM, Pereira IA. Hydrogen as an energy 
source for the human pathogen Bilophila wadsworthia. Antonie Van Leeuwenhoek. 
2008;93:381-390. 
[74] Carbonero F, Benefiel AC, Gaskins HR. Contributions of the microbial hydrogen economy 
to colonic homeostasis. Nat Rev Gastroenterol Hepatol. 2012;9:504-518. 
[75] Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in 
colonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3:448. 
[76] Amaretti A, Raimondi S, Leonardi A, Quartieri A, Rossi M. Hydrolysis of the rutinose-
conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria. Nutrients. 
2015;7:2788-2800. 
[77] Bang SH, Hyun YJ, Shim J, Hong SW, Kim DH. Metabolism of rutin and poncirin by 
human intestinal microbiota and cloning of their metabolizing alpha-L-rhamnosidase from 
Bifidobacterium dentium. J Microbiol Biotechnol. 2015;25:18-25. 
[78] Guadamuro L, Dohrmann AB, Tebbe CC, Mayo B, Delgado S. Bacterial communities and 
metabolic activity of faecal cultures from equol producer and non-producer menopausal women 
under treatment with soy isoflavones. BMC Microbiol. 2017;17:93-017-1001-y. 
[79] Koren O, Knights D, Gonzalez A, Waldron L, Segata N, Knight R, Huttenhower C, Ley RE. 
A guide to enterotypes across the human body: meta-analysis of microbial community structures 
in human microbiome datasets. PLoS Comput Biol. 2013;9:e1002863. 
[80] Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap 
J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, 
Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, 
Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte 
E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, MetaHIT 
Consortium, Antolin M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux 
C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, 
Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, 
Lakhdari O, Layec S, Le Roux K, Maguin E, Merieux A, Melo Minardi R, M'rini C, Muller J, 
Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, 
Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P. 
Enterotypes of the human gut microbiome. Nature. 2011;473:174-180. 
[81] Tomas-Barberan FA, Gonzalez-Sarrias A, Garcia-Villalba R, Nunez-Sanchez MA, Selma 
MV, Garcia-Conesa MT, Espin JC. Urolithins, the rescue of 'old' metabolites to understand a 
72 
 
'new' concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and 
host health status. Mol Nutr Food Res. 2016. 
[82] Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, Newton K, Gaskins HR, O'Keefe 
SJ. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African 
Americans. Am J Clin Nutr. 2013;98:111-120. 
[83] O'Keefe SJ, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, Posma JM, Kinross J, Wahl 
E, Ruder E, Vipperla K, Naidoo V, Mtshali L, Tims S, Puylaert PG, DeLany J, Krasinskas A, 
Benefiel AC, Kaseb HO, Newton K, Nicholson JK, de Vos WM, Gaskins HR, Zoetendal EG. 
Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 2015;6:6342. 
[84] Gomez A, Petrzelkova KJ, Burns MB, Yeoman CJ, Amato KR, Vlckova K, Modry D, Todd 
A, Jost Robinson CA, Remis MJ, Torralba MG, Morton E, Umana JD, Carbonero F, Gaskins 
HR, Nelson KE, Wilson BA, Stumpf RM, White BA, Leigh SR, Blekhman R. Gut Microbiome 
of Coexisting BaAka Pygmies and Bantu Reflects Gradients of Traditional Subsistence Patterns. 
Cell Rep. 2016;14:2142-2153. 
[85] Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, Turroni S, 
Biagi E, Peano C, Severgnini M, Fiori J, Gotti R, De Bellis G, Luiselli D, Brigidi P, Mabulla A, 
Marlowe F, Henry AG, Crittenden AN. Gut microbiome of the Hadza hunter-gatherers. Nat 
Commun. 2014;5:3654. 
[86] Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, 
Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman 
FD, Lewis JD. Linking long-term dietary patterns with gut microbial enterotypes. Science. 
2011;334:105-108. 
[87] Miquel S, Martin R, Rossi O, Bermudez-Humaran LG, Chatel JM, Sokol H, Thomas M, 
Wells JM, Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin 
Microbiol. 2013;16:255-261. 
[88] Chung WS, Walker AW, Louis P, Parkhill J, Vermeiren J, Bosscher D, Duncan SH, Flint 
HJ. Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC 
Biol. 2016;14:3-015-0224-3. 
[89] Hooda S, Boler BM, Serao MC, Brulc JM, Staeger MA, Boileau TW, Dowd SE, Fahey 
GC,Jr, Swanson KS. 454 Pyrosequencing Reveals a Shift in Fecal Microbiota of Healthy Adult 
Men Consuming Polydextrose Or Soluble Corn Fiber. J Nutr. 2012;142:1259-1265. 
[90] Flint HJ, Duncan SH, Scott KP, Louis P. Interactions and competition within the microbial 
community of the human colon: links between diet and health. Environ Microbiol. 2007;9:1101-
1111. 
[91] Flint HJ, Bayer EA. Plant cell wall breakdown by anaerobic microorganisms from the 
Mammalian digestive tract. Ann N Y Acad Sci. 2008;1125:280-288. 
73 
 
[92] Flint HJ. Polysaccharide breakdown by anaerobic microorganisms inhabiting the 
Mammalian gut. Adv Appl Microbiol. 2004;56:89-120. 
[93] Power KA, Lu JT, Monk JM, Lepp D, Wu W, Zhang C, Liu R, Tsao R, Robinson LE, Wood 
GA, Wolyn DJ. Purified rutin and rutin-rich asparagus attenuates disease severity and tissue 
damage following dextran sodium sulfate-induced colitis. Mol Nutr Food Res. 2016;60:2396-
2412. 
[94] Li Z, Summanen PH, Komoriya T, Henning SM, Lee RP, Carlson E, Heber D, Finegold 
SM. Pomegranate ellagitannins stimulate growth of gut bacteria in vitro: Implications for 
prebiotic and metabolic effects. Anaerobe. 2015;34:164-168. 
[95] Morais CA, de Rosso VV, Estadella D, Pisani LP. Anthocyanins as inflammatory 
modulators and the role of the gut microbiota. J Nutr Biochem. 2016;33:1-7. 
[96] Huang J, Chen L, Xue B, Liu Q, Ou S, Wang Y, Peng X. Different Flavonoids Can Shape 
Unique Gut Microbiota Profile In Vitro. J Food Sci. 2016;81:H2273-9. 
[97] Parkar SG, Trower TM, Stevenson DE. Fecal microbial metabolism of polyphenols and its 
effects on human gut microbiota. Anaerobe. 2013;23:12-19. 
[98] Tomas-Barberan F, Garcia-Villalba R, Quartieri A, Raimondi S, Amaretti A, Leonardi A, 
Rossi M. In vitro transformation of chlorogenic acid by human gut microbiota. Mol Nutr Food 
Res. 2014;58:1122-1131. 
  
 
 
 
 
 
 
 
  
74 
 
Table 8: Phenolic profiling of cherry concentrated juices (NQ: Not quantified). 
 Phenolic compound Concentration (mg/100g) 
  King 
Orchard 
Royal 
Farms 
Tree of Life 
Hydroxycinnamic 
acids 
Chlorogenic acid 25.5±1.9 22.8±1.9 3.6±0.1 
Neochlorogenic acid 21.1±2.5 33.9±1.8 39.2±5.5 
Caffeoyl-quinic acid 
isomers 
NQ 
 
Coumaroyl-quinic acid 
isomers 
NQ 
 
Feruloylquinic acid NQ 
 
Di-caffeoyl-quinic acid 
 
NQ 
 
Flavonoid 
Rutin 10.3±0.5 6.0±0.1 5.0±0.2 
Kaempferol-rutinoside 3.6±0.3 1.9±0.1 0.8±0.1 
Quercetin-deoxyhexose--
exose-hexose 
NQ 
 
Isorhamnetin-
deoxyhexose-hexose 
 
NQ 
 
Anthocyanidins 
Keracyanin* 1.4±0.2 0.3 1.4±0.0 
Cyanidin-dH-H-H*  4.9±0.3 4.4±0.2 <0.02 
* Cyanidin compounds quantification was carried out based on cyanidin-glucoside standard, 
therefore given concentrations are cyanidin-glucoside equivalents. 
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Table 9: Demographic and dietary intake data of the High and Low Bacteroides groups. 
 
High Bacteroides Low Bacteroides T-test 
Gender 3M-2F 1M-2F 
 
Age 26.2 25.5 0.379 
BMI 26.1 22 0.068 
Avg FBG 90.1 89.6 0.445 
kilocalories 1543 1830 0.161 
Protein (g) 75 75 0.49 
CHO (g) 134.4 197.6 0.049 
Fat (g) 70.3 83.5 0.2 
Alcohol (g) 12.6 3.4 0.038 
Cholesterol (mg) 279.2 362.2 0.182 
SFA (g) 21.3 27.3 0.122 
MUFA (g) 28.1 32.6 0.26 
PUFA (g) 15.5 17.1 0.342 
PRO % 19.42 16.2 0.152 
CHO % 34.3 42.2 0.034 
Fat % 40.4 40.3 0.488 
Alcohol % 5.86 1.3 0.028 
Fiber (g) 10.8 21.62 0.04 
Sugar (g) 51.2 78.9 0.018 
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Figure 1: Polyphenol metabolomics; Microbial degradation of the main native tart cherry 
polyphenols over the 48 hours of microbial fermentation in vitro A and B. Tart cherry and C. 
Sweet cherry concentrate juices; and detection of major metabolites from chlorogenic acid (DEF) 
and proanthocyanins (GHI) for King Orchard (DG) and All Natural (EH) tart cherry juices and 
Sweet cherry juice (FI). 
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Figure 2: Dynamics (phylum level) of microbiota in in vitro fermentation for A. Control, B. 
Apricots, C. All tart cherries and D. all polyphenols standards. 
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Figure 3: Tart cherries impact on in vitro gut microbiota. (A) Non-metric Multidimensional 
Scaling (NMDS) of control (filled squares), tart cherries (+) and sweet cherries (filled circles); 
(B) Relative abundances of significantly modulated taxa for all tart cherries samples 
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Figure 4: Apricots impact on in vitro gut microbiota. (A) NMDS of control (filled squares), and 
apricots (open diamonds); (B) Relative abundances of significantly modulated taxa for all 
apricots samples. 
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Figure 5: Pure polyphenols impact on in vitro gut microbiota: relative abundances of 
significantly modulated taxa. 
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Figure 6: Stool microbiota dynamics (NMDS and phylum level) for human volunteers with A. 
High Bacteroides and B. Low Bacteroides initially; before (green) and after (red) dietary 
intervention with daily tart cherry juice consumption 
82 
 
 
 
 
 
Figure 7: Bacterial genera significantly affected by tart cherry consumption for A the high 
Bacteroides group and B the low Bacteroides group. 
 
83 
 
Chapter 3 
OVERALL CONCLUSION 
 
The results of this research provide evidence and confirm an active intervention of the gut 
microbiota over the metabolism of polyphenols contained in tart cherry concentrate juices as 
well as fresh fruits. Additionally, the initial gut microbiota composition of an individual 
determines the ability to metabolize efficiently polyphenols into bioactive microbial metabolites 
with potential health benefits. Finally, such approaches are suggested when studying the 
association of polyphenols over any health claims.  
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